[go: up one dir, main page]

NZ222839A - Appliance for subcutaneous or intradermal injection of a liquid formulation - Google Patents

Appliance for subcutaneous or intradermal injection of a liquid formulation

Info

Publication number
NZ222839A
NZ222839A NZ222839A NZ22283987A NZ222839A NZ 222839 A NZ222839 A NZ 222839A NZ 222839 A NZ222839 A NZ 222839A NZ 22283987 A NZ22283987 A NZ 22283987A NZ 222839 A NZ222839 A NZ 222839A
Authority
NZ
New Zealand
Prior art keywords
appliance according
appliance
needle
vessel
supply vessel
Prior art date
Application number
NZ222839A
Inventor
Giorgio Cirelli
Hans Steffen
Christian Surber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ222839A publication Critical patent/NZ222839A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/14586Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of a flexible diaphragm
    • A61M5/14593Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of a flexible diaphragm the diaphragm being actuated by fluid pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M2005/14204Pressure infusion, e.g. using pumps with gas-producing electrochemical cell
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/14252Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M2005/14264Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body with means for compensating influence from the environment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M2005/14268Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body with a reusable and a disposable component
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16877Adjusting flow; Devices for setting a flow rate
    • A61M5/16881Regulating valves
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/12Pressure infusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polarising Elements (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Surgical Instruments (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Nozzles (AREA)

Abstract

The portable appliance is of use for the subcutaneous or intradermal injection of a liquid formulation of an active principle and it comprises in combination: a supply vessel for the formulation; an injection needle adapted to communicate with the vessel; pump means for emptying the vessel through the injection needle; securing means for securing the appliance to an appropriate part of the patient's body; and needle-driving means for shooting the injection needle into the patient's skin.

Description

<div class="application article clearfix" id="description"> <p class="printTableText" lang="en">22 2 8 39 <br><br> Priority Date(s): . <br><br> Complete Specification Filed: <br><br> Class: .MlMS/A^ <br><br> Publication Date: P.O. Journal. No: <br><br> O ■ o • i » 11 <br><br> NEW ZEALAND <br><br> PATENTS ACT. J 953 <br><br> No.: <br><br> Date: <br><br> COMPLETE SPECIFICATION APPLIANCE FOR INJECTION OF LIQUID FORMULATIONS^^1 <br><br> e \ <br><br> /, <br><br> 1:) <br><br> S , '8D£c&gt;987Sii <br><br> +•/We, F.HOFFMANN-LA ROCHE &amp; CO. AKTIENGESELLSCHAFT 124-184 Grenzacherstrasse, Basle, Switzerland a Swiss company <br><br> hereby declare the invention for which-!"/ we pray that a patent may be granted to-wie-/us, and the method by which it is to be performed, to be particularly described in and by the following statement: - <br><br> - 1 - <br><br> (followed by page la) <br><br> 222839 <br><br> la <br><br> 5 <br><br> The invention relates to a portable appliance for the subcutaneous or intradermal injection of a liquid formulation of an active principle. <br><br> There has for some time past clearly been a need for 10 small, compact and portable injection appliances which can be worn on a suitable part of the body and which provide a preferably subcutaneous release of accurately defined quantities of active principles into the body over prolonged periods of time. Various devices of this kind having -|5 considerable advantages over the conventional subcutaneous syringe are already known. In conventional subcutaneous injection a so-called bolus of an active principle is introduced into the body and must be gradually absorbed and distributed therein. Distribution depends to a considerable 20 extent upon the physiological circumstances of the individual being treated and is therefore uncontrollable. The advantage of appliances which release an active principle continuously over a prolonged period of time is that administration can be accurately controlled to suit the 25 body's requirements. Indeed, it is possible for phases of release to alternate with phases of non-release. A physiologically adapted release of this kind is advantageous more particularly in the case of highly active agents such as insulin, interferon or the like. <br><br> Conventionally, known appliances of this kind have a vessel which contains the active principle and with which an injection needle communicates. Pump means discharge the contents of the vessel into the body over a predetermined period of time. U.K. <br><br> 30 <br><br> 35 <br><br> Patent Specification No. 2077110 <br><br> O O ^ 0 '7 - <br><br> d. &lt;L. L- O w' / <br><br> - 2 - <br><br> appliance. It has a supply vessel in the form of a hose which a clockwork-driven squeezing roller empties through an injection needle connected to the end of the hose. The needle is introduced into the tissue some distance away from 5 the appliance. The appliance can be worn or carried on the wrist like a wrist watch. An appliance of a different kind disclosed in US P 4 552 561 can be stuck to the skin and carries the injection needle on its underside so that the place where the needle penetrates the skin is covered while 10 the appliance is in use. This appliance also needs the needle to pierce the tissue. It is more particularly the piercing of the tissue with the needle that is problematic in the case of conventional subcutaneous bolus injections and in the case of the more recent subcutaneous injection 15 appliances hereinbefore referred to. People who are not experts in medicine are usually insufficiently practised to place such a needle correctly and they suffer from a completely justified fear of the likely pain. <br><br> 20 It is the object of the invention to prepare a portable injection appliance of the kind hereinbefore set out which is free from the disadvantages of the known appliances and which can readily be used more particularly by persons not expert in medicine. <br><br> 25 <br><br> According to the invention, this is achieved by an appliance of the kind hereinbefore referred to which is distinguished by a combination comprising: a supply vessel for the formulation; an injection needle adapted to 30 communicate with the vessel; pump means for emptying the vessel through the injection needle; securing means for securing the appliance to an appropriate part of the <br><br> ' \ E N &gt; <br><br> patient's body; and needle-driving means for shooting ttj^ injection needle into the patient's skin. v <br><br> 35 i28JAN!99I <br><br> The!, appliance can also comprise flow control means\ ^ <br><br> enabling the release of active principle either to be kept£Lfr <br><br> 222839 <br><br> 3 <br><br> constant or to follow a predetermined profile. <br><br> According to another feature of the invention, the appliance is in two parts, the part containing the more 5 valuable elements being reusable while the other part can be discarded as an expendable item after being used once. <br><br> The vessel for the active principle or the solution thereof can quite simply be. for example, a part of the 10 appliance casing, in which case an appropriate diaphragm which is made of elastomers or metals or the like in single or multilayer form delimits a chamber-. Another possibility for a supply vessel is a closed vessel also made of elastomers or metals or the like, for example, in the form 15 of bellows. The supply vessel can also take the form of a squeezable hose such as referred to by way of example in the introduction hereof. The vessel can also take the form of a plunger syringe whose cylinder is operative as supply vessel. An absorbent material like a sponge can be used to 20 take up the active principle. More than one separate supply vessels or chambers can be provided, for example, when two active principles have to be injected or when a lyophilisate of active principle and a reconstituting solvent are used. Various forms of energy can be considered 25 for driving the vessel-emptying pump means. For instance, the pump can be gas- operated, in which event the pressure necessary to empty the vessel can be produced by electrolysis or photolysis or chemical reactions and by propellant vapours such as Freon or the like. Another 30 possibility is to produce the requisite pressure by ordinary osmosis or electro-osmosis. Mechanical drives using, for example, springs or bimetallic elements or memory alloys or clockwork drives are of course another possibility. Electric or magnetic drives such as the known electric pumps, 35 diaphragm pumps, piezoelectric pumps, electric clock, dti-vves^;^ <br><br> or magnets can also be considered. <br><br> O O" O 7 Q LC-L.^ J <br><br> - 4 - <br><br> 10 <br><br> An adhesive layer on Che patient-engaging surface of the appliance, such Layer possibly extending as a piaster beyond the appliance, is more particularly suitable for securing the appliance to the appropriate part of the patient's body. A possible alternative is a securing band or tape like the armband shown in U.K. Patent Specification No. 2077110 hereinbefore mentioned. <br><br> The needle-driving device is preferably a metal spring. <br><br> For constant flow operation the active principle is arranged to be released constantly, for example, by means of capillaries or frits or diaphragms. Also, the flow can be adjusted by adaptation of the viscosity of the liquid 15 formulation of the active principle. <br><br> Control of the quantity of active principle released can also be embodied in various ways. For example, a squeezable hose whose diameter is increased or reduced to suit 20 requirements can be disposed between the supply vessel and the needle. Another possibility is to provide a pressure-reducing valve. Another possibility is to select a particular range of the expansion of the driving spring or to use special cup springs in which the force is constant 25 within limits over a distance. More elaborate flow control can be provided by feedback using sensors. Flow control can also be on the basis of a specially programmed pumping mechanism being used for the vessel-emptying operation. <br><br> 30 Very thin capillaries - i.e., capillaries having a diameter of preferably &lt; 0.5 mm are used as injection needles, since pain increases with needle thickness. Th||V depth of penetration and the way in which the needle vg T <br><br> ground also have a bearing on pain. Advantageously, i"28JANI99| 35 therefore, the penetration depth is at most 5 000 y.m. ^ <br><br> Also, the needle is preferably ground at an inclination,^£^L&gt;l'''i' example, like a lancet. <br><br> # <br><br> o o ? o ^ ^ <br><br> C. t— &lt;_ vj —' / <br><br> - 5 - <br><br> Even though needle diameter and penetration depth do not cause pain, the formulation itself may cause pain or irritation. This can be countered by a local anesthetic in the formulation. <br><br> 5 <br><br> Embodiments of the invention will be described hereinafter with reference to the accompanying drawings wherein: <br><br> 10 Fig. 1 is a cross-section through an injection appliance according to the invention; <br><br> Fig. 2 is a plan view corresponding to Fig. 1; <br><br> Fig. 3 is a cross-section through another embodiment of the invention; <br><br> 15 Fig. 4 is a plan view with partial sectioning of the appliance shown in Fig. 3; <br><br> Fig. 5 is a cross-section through another embodiment of the invention; <br><br> Fig. 6 is a section on the plane B-B of Fig. 5; <br><br> 20 Fig. 7 is a cross-section through another embodiment of the invention: <br><br> Fig. 8 is a section on tha plane A-A through the appliance of Fig. 7, and <br><br> Fig. 9 is a section through another embodiment of the <br><br> 25 invention on a plane perpendicular to the axis. <br><br> The appliance shown in Figs. 1 and 2 comprises a two-part flat cylindrical casing having a bottom part I and a top part 2. The two parts 1, 2 are rigidly interconnected, <br><br> 30 for example, by screwthreading (hot shown). Annular recesses in the contacting surfaces of the two parts l. 2 together form an annular chamber 3. A diaphragm 4 subdivides the same into two separate chambers, both of which communicate with the exterior by way of filling orifices 5. 6 normally closed.. <br><br> 35 by plugs. ^ <br><br> -;'v ^ <br><br> \2S JAN 1991 <br><br> \ <br><br> o O O O 7 Q L. L. c. o ^ ■*&gt; ;- 6 - ;An injection needle 7 and driving means for shooting the same are disposed at the centre of the discoid casing. The needle is a steel capillary of 200 vm diameter. ;Alternatively, a glass capillary could be used. A carrier 8 5 carries the needle 7. The carrier 8 has a bottom cylindrical part and a top flat discoid part. The cylindrical pact is disposed for axial movement in a corresponding bore 9 in the casing bottom part 1 and is formed with a bore 10 which extends perpendicularly to its axis and which communicates 10 with the interior of the needle 7. The cylindrical outside surface of the cylindrical part is formed with three peripheral grooves in which 0-ring seals are introduced. ;There is also a shallow peripheral groove at the level of the bore 10. ;15 ;In its bottom part the bore 9 reduces to a diameter just large enough for the needle to pass through. ;The top discoid part of the needle carrier 8 is disposed 20 for axial movement in a corresponding further concentric bore 11 of the casing top part 2. Over substantially two-thirds of the thickness of the part 2 the bore 11 reduces to substantially half its diameter so that an abutment is formed. Disposed between the same and the top 25 part of the needle carrier 8 is a driving spring 12 for driving the needle into the patient's skin. ;The needle carrier 8 also has resilient retaining fingers 13 which extend upwards from its surface and which 30 have a pawl-like step or shoulder engaging the edge of a widening of the bore 11. When the fingers 13 are in the engaged state the carrier 8 with the needle 7 is in its top position in which the spring 12 is under stress and the needle does not project beyond the casing bottom surface~.28 JANJ99} ;35 O/ ;Disposed between the fingers 13 is a safety cover or 14 which prevent accidental compression of the fingers 13 ;222839 ;- 7 - ;likely to trigger the needle drive. The safety cover 14 is formed on its other side with a bore whose diameter is so adapted to appropriate inclined surfaces of the fingers 13 that the same are pressed together when the cap 14 is pressed on so that the retaining mechanism is released. ;A communicating bore 15 is disposed in the casing bottom part between the bottom compartment of the chamber 3 and the bore 9. The same widens over some of its length to receive a 10 restrictor element, such as a Teflon frit. The bore 15 so extends as to join the bore 9 at a height corresponding to the bore 10 in the needle carrier 8 when the same is in its bottom position. In the top end position the opening where the bore 15 joins the bore 9 is closed by the cylindrical 15 part of the needle carrier 8 and by the bottom two 0-rings. ;The appliance has an adhesive layer 16 on its underside. The appliance is also embedded in a correspondingly shaped securing plaster 17. The layer 16 and the adhesive layer of 20 the plaster are protected before use by a foil 18. The adhesive layer 16 on the underside and the adhesive layer of the plaster can contain additional substances such as a local anesthetic. ;25 In production, after the appliance has been assembled the bottom compartment of the chamber 3 is filled with a required active principle by way of the aperture 5, ;whereafter the same is closed. Also, the top compartment of the chamber 3 is filled with a propellant through the 30 aperture 6. These fillings are usually production operations and in that case are not carried out by the user. However, ;in the case of some active principles it may be convenient to carry out filling shortly before use. The appliance is then ready for use. ,-/V4 ~^ ;35 yq ;•V ;°li ;The appliance operates as follows: ;f 28 JAN 19917 ;V - „/ ;222839 ;- 8 - ;The user removes the foil 18 and sticks the appliance to an appropriate part of his body by means of the plaster 17 and adhesive foil 16. The user then removes the safety cap ;14. turns it and presses it onto the inclined surfaces of 5 the fingers 13. The same are therefore compressed and release the needle drive. The spring 12 expands and presses the needle carrier 8 with the needle 7 downwards through the predetermined distance and through the adhesive foil onto the user's skin. The needle should penetrate something like 10 at least 50 um and at most approximately 5000 um into the skin. The piercing of the skin by the needle is painless or nearly so because of the reduced depth of penetration, the small diameter of the needle and its inclined grinding. ;15 Simultaneously as the needle carrier 8 descends the cross-bore 10 moves to the height of the opening of the communicating bore 15 so that the same communicates with the needle 7. The way is then open for the active principle to flow through the needle, the flow being determined by the 20 pressure of the propellant in the top compartment of the chamber 3 and by the restriction provided by the restrictor ;15. The volume of the flow of active principle and, ;therefore, the duration of injection can be determined by appropriate choice of these factors. ;25 ;The appliance shown in Figs. 3 and 4 has the same storage vessel and the same needle-shooting device as the embodiment hereinbefore described. An additional feature, operative to compensate for variations in the pressure of 30 the propellant is a pressure-reducing valve. The same is disposed in a segment of the circular casing. ' ;Correspondingly, the chamber 3 extends around only some^of the periphery. i'Y ;\ ;O! ;i 28 JAN 1991' ;35 The reducing valve has its own casing which is received m a corresponding recess in the appliance casing. Internally the reducing valve is subdivided by a diaphragm ;0 ;2228 ;- 9 - ;20, in a manner conventional in pressure-reducing valves, into a high-pressure chamber 21 and a low-pressure chamber 22. A ram 23 is disposed in the communicating bore between the chambers 21 and 22, is secured to the diaphragm 20 at 5 its centre and can close the communicating orifice by moving axially. A spring 24 is disposed on the other side of the diaphragm between the ram 23 and an adjustable abutment 25. The spring 24 basically determines the pressure in the low-pressure chamber. The high- pressure chamber 21 10 communicates by way of a communicating bore 26 with the bottom compartment of the chamber 3 - i.e.. the reservoir of active principle. The low-pressure chamber 22 communicates by way of bore 27 with the central bore 9 and, as in the embodiment hereinbefore described, opens out at the level of 15 the cross-bore 10 when the needle carrier is in its bottom end position. ;The pressure-reducing valve enables a substantially constant release rate of active principle to be maintained 20 irrespective of pressure variations on the high-pressure side. Such pressure variations may be caused by variations in the vapour pressure of the propellant as a result of temperature variations. ;25 ;As in the previous example the appliance shown in Fig^. ' 3 and 4 also has an adhesive layer, a securing plaster aicid a ;I ;protective foil and operates in virtually the same way a's" ?8 ;\ *" <br><br> the embodiment previously described. <br><br> 30 In the embodiment shown in Figs. 5 and 6 an alternative facility for conveying the active principle and a different form of reservoir are provided. The reservoir is in the form of two bags or bubbles or bellows 28 formed on one side with an aperture via which they are secured to a mount 29 formed 35 with a filling aperture 30 and a bore 31 communicating with the central bore 9. The two mounts 29 are rigidly connected to the central cylindrical part of the casing bottom part 1. <br><br> 3 0 ? 0 ? Q <br><br> &lt;L c. t_ J <br><br> - 10 - <br><br> A rotating member 32 is disposed around this stationary pact and has two inwardly projecting webs 33 each engaging with the bacKs of the bags 28. <br><br> 5 Between the member 32 and the outside wall of the casing top part 2 is a compartment receiving a spiral spring 34. <br><br> The same is secured at one end in the casing wall and at its other end in the member 32. When the spiral spring 34 expands, it rotates the member 32, the webs thereof 10 compressing the bags 28 so that the active principle therein empties through the orifices 31. <br><br> By using just some of the usable number of turns of the spiral spring 34 to produce the rotary movements, a control 15 effect is achieved. Consequently, the driving spring is operative both to convey the active principle and to control flow. In other respects this embodiment operates similarly to the embodiment shown in Figs. 1 and 2. <br><br> 20 In contrast to the embodiments so far described, the appliance shown in Figs. 7 and 8 has two supply vessels or chambers 35, 36 and two separate needle carriers 39, 40 which have needles 37, 38 and which a common activating mechanism 41 drives. This embodiment is of use when it is 25 required to inject two active principles simultaneously and separately. <br><br> As an alternative to the version shown, a single needle carrier having two needles could be provided instead of the 30 two needle carriers with two needles, in which event th^c EW <br><br> sealing system would have to be more elaborate. //^ <br><br> ijN <br><br> |3f f £ <br><br> The embodiment shown in section in Fig. 9 has \ JAM99I j electrically driven conveyance of the active principle^^^^^-^ 35 Because of the relatively high cost of the electrical elements of this embodiment the appliance is divided into a discardable part 42 and a reusable part 43. The two parts <br><br> 222839 <br><br> - ii - <br><br> 42, 43 are interconnected by resilient clips 56 which engage in corresponding recesses. <br><br> The disposable part 42 comprises a supply vessel 55 with 5 provision for filling closed by a partition 44. The system is such that the reservoir can, if required, be filled shortly before use. The disposable part 42 also comprises pump means 45 having an intake valve 46 communicating with the supply vessel, a delivery valve 49 controlling a line 47 10 to an injection needle 48, and a plunger pump 50 disposed between and connected to the two valves. The pump means 45 operate as follows: when the plunger of the pump 50 is drawn back from the position shown a predetermined volume is intaken through the intake valve 46 from the supply vessel. 15 The delivery valve 49 stays closed in this phase. When the piston makes its next advance, the intake valve 46 closes and the delivery valve 49 opens so that the intaken volume is supplied to the injection needle. <br><br> 20 The injection needle together with the needle carrier and the piercing mechanism (not shown here) also forms part of the discardable part. <br><br> The more valuable reusable part 43 contains the electric 25 drive for the pump means, in the form of an electromagnet 51 which draws the plunger of the pump 50 back, the plunger being advanced by a return spring 52. Ah electronic control facility 53 controls the electromagnet 51. A battery 54 provides power for the electromagnet 51 and the electronic 30 control 53. v <br><br> ("28 JANI99I <br><br> An electrically driven pump is particularly suitable fo combination with electronic control of the release quantity. 35 The release profile can. for example, be pre-programmed and stored in some suitable way. The release rate can be checked by appropriate sensors. <br><br> 22 2 8 3 <br><br> - 12 - <br><br> 9 <br><br> In the embodiments shown the needle-driving means have been combined with the operation of the valve. These two operations can readily be separated so that, for example, first the needle is shot, whereafter a valve opens separately. Skin-piercing movements other than simple injection perpendicularly to the skin surface are possible; for example, the vertical piercing movement can be coupled with rotation of the needle or the needle can be injected into the skin at an inclination to the skin surface. <br><br></p> </div>

Claims (27)

<div class="application article clearfix printTableText" id="claims"> <p lang="en"> 222839<br><br> - 13 -<br><br> WHAT WE CLAIM IS:<br><br>
1. A portable appliance for the subcutaneous or intradermal injection of a liquid formulation of an active principle, characterised by a combination comprising: a supply vessel for the formulation; an injection needle adapted to communicate with the vessel;pump means for emptying the vessel through the injection needle; securing means for securing the appliance to an appropriate part of the patient's body; and needle-driving means for shooting the injection needle into the patient's skin and bringing the injection needle into communication with the vessel.<br><br>
2. An appliance according to claim 1,. including flow control means in the supply vessel.<br><br>
3. An appliance according to claim 1, characterised in that the appliance is in two parts, one of which is reusable and the other of which is discardable.<br><br>
4. An appliance according to claim 3, characterised in that the discardable part comprises the supply vessel and the reusable part comprises means for driving the pump means.<br><br>
5. An appliance according to claim 1, characterised in that the supply vessel is a chamber in the appliance, the chamber being separated into two chambers by a diaphragm.<br><br>
6. An appliance according to claim 1, characterised in that the supply vessel is in the form of bellows.<br><br>
7. An appliance according to claim 1, characterised in that the supply vessel is in the form of a squeezable hose.<br><br>
8. An appliance according to claim 1, characterised in that the supply vessel is in the form of a plunger syringe<br><br> /'&lt;h<br><br> P - "I<br><br> | 2 8 JAN I £1<br><br> 222839<br><br> 14<br><br> whose cylinder is operative as supply vessel.<br><br>
9. An appliance according to any one of claims 6-9, characterised in that an absorbent material is provided in the supply vessel to take up the active principle.<br><br>
10. An appliance according to claim 1, characterised in that more than one supply vessel is provided.<br><br>
11. An appliance according to claim 1, characterised in that the pump means comprise a chamber which is separated from the supply vessel by a resilient diaphragm -and in which pressure-producing means are provided.<br><br>
12. An appliance according to claim 11, characterised in that the chamber is filled with propellant vapour.<br><br>
13. An appliance according to claim 11, characterised in that an electrochemical, photochemical or chemical pressure producing system is provided in the chamber.<br><br>
14. An appliance according to claim 11, characterised in that an osmosis or electro-osmosis system is provided in the chamber.<br><br>
15. An appliance according to claim 1, characterised in that the pump means comprise a mechanical drive.<br><br>
16. An appliance according to claim 15, characterised in that the mechanical drive comprises a spring, a bimetallic element, a memory alloy or a clockwork drive.<br><br>
17. An appliance according to claim 1, characterised in that the pump means comprise an electric or magnetic drive.<br><br>
18. An appliance according to claim 17, wherein the electric or magnetic drive comprises an electric " ' " 'iragm pump or<br><br> 2p9o *?<br><br> &lt;-Kj<br><br> 15<br><br> O<br><br> piezoelectric pump or electric clock drive or an electromagnet.<br><br>
19. An appliance according to claim 1, characterised in that the securing means are in the form of an adhesive layer.<br><br>
20. An appliance according to claim 1, characterised in that the securing means comprises a plaster.<br><br>
21. An appliance according to claim 19 or 20, characterised in that the securing means comprises an adhesive layer containing a local anesthetic.<br><br>
22. An appliance according to claim 1, characterised in that the needle has a diameter of &lt; 0.5 mm.<br><br>
23. An appliance according to claim 1, characterised in that the needle-driving means are combined with a valve controlling communication between the supply vessel and the needle.<br><br>
24. An appliance according to claim 16, characterised in that only a fraction of the spring deflection of a driving spring is used.<br><br>
25. An appliance according to claim 1, characterised in that electronic control means for controlling the pump means are provided the control means having a data memory for a programmed release profile.<br><br>
26. An appliance according to claim 1, characterised in that the vessel is formed with apertures which are closed by a partition and through which the vessel is filled shortly before use.<br><br>
27. An appliance according to claim 25, characterised in that electronic control means includes sensors to control or vary the release rate of the liquid formulation.<br><br> </p> </div>
NZ222839A 1986-12-18 1987-12-08 Appliance for subcutaneous or intradermal injection of a liquid formulation NZ222839A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH502186 1986-12-18

Publications (1)

Publication Number Publication Date
NZ222839A true NZ222839A (en) 1991-03-26

Family

ID=4286578

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ222839A NZ222839A (en) 1986-12-18 1987-12-08 Appliance for subcutaneous or intradermal injection of a liquid formulation

Country Status (15)

Country Link
US (1) US4886499A (en)
EP (1) EP0272530B1 (en)
JP (1) JP2648314B2 (en)
KR (1) KR960000845B1 (en)
AT (1) ATE68358T1 (en)
AU (1) AU620536B2 (en)
CA (1) CA1283827C (en)
DE (1) DE3773867D1 (en)
DK (1) DK170660B1 (en)
HK (1) HK27494A (en)
IE (1) IE60868B1 (en)
IL (1) IL84811A (en)
NZ (1) NZ222839A (en)
PH (1) PH26445A (en)
ZA (1) ZA879351B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5848990A (en) * 1993-10-22 1998-12-15 Hoffmann-La Roche Inc. Device for introducing active substance into a patient

Families Citing this family (723)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894054A (en) * 1988-06-20 1990-01-16 Miskinyar Shir A Preloaded automatic disposable syringe
JPH02307477A (en) * 1989-05-22 1990-12-20 Kobayashi Shogo Continuous injector for medical fluid
US5656032A (en) * 1989-06-16 1997-08-12 Science Incorporated Fluid delivery apparatus and method of making same
US5167633A (en) * 1990-11-29 1992-12-01 Pacesetter Infusion, Ltd. Liquid-vapor pressure reservoir for medication infusion pump
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
EP0582932A1 (en) * 1992-08-11 1994-02-16 F. Hoffmann-La Roche Ag Therapeutic system for the parenteral administration of hematopoietic growth factors
EP0582933A1 (en) * 1992-08-11 1994-02-16 F. Hoffmann-La Roche Ag Therapeutic system for the parenteral administration of hematopoietic growth factors
US5997501A (en) * 1993-11-18 1999-12-07 Elan Corporation, Plc Intradermal drug delivery device
US5352201A (en) * 1994-02-03 1994-10-04 Block Medical, Inc. Compact uniform pressure infusion apparatus
US5443450A (en) * 1994-04-29 1995-08-22 Medtronic, Inc. Medication delivery device and method of construction
US5445616A (en) * 1994-04-29 1995-08-29 Medtronic, Inc. Medication delivery device and method of construction
CA2159052C (en) 1994-10-28 2007-03-06 Rainer Alex Injection device
US5575770A (en) * 1995-04-05 1996-11-19 Therex Corporation Implantable drug infusion system with safe bolus capability
US6224572B1 (en) * 1995-05-04 2001-05-01 Sarcos L.C. Piston-actuated attachable topical fluid delivery system
CA2151407A1 (en) * 1995-06-09 1996-12-10 Duncan Newman Injection device
AU7093096A (en) * 1995-09-05 1997-03-27 Elan Medical Technologies Limited Chemically driven liquid delivery pumping device
IE77523B1 (en) * 1995-09-11 1997-12-17 Elan Med Tech Medicament delivery device
US5735818A (en) * 1995-10-11 1998-04-07 Science Incorporated Fluid delivery device with conformable ullage
US5693018A (en) * 1995-10-11 1997-12-02 Science Incorporated Subdermal delivery device
US5858001A (en) * 1995-12-11 1999-01-12 Elan Medical Technologies Limited Cartridge-based drug delivery device
US5785688A (en) * 1996-05-07 1998-07-28 Ceramatec, Inc. Fluid delivery apparatus and method
EP0910420B1 (en) * 1996-06-10 2003-02-05 ELAN CORPORATION, Plc Needle for subcutaneous delivery of fluids
IE80772B1 (en) * 1996-06-10 1999-02-10 Elan Corp Plc Delivery needle
US6558900B2 (en) * 1996-07-12 2003-05-06 Emory University Regulation of apoptosis and in vitro model for studies thereof
US6186982B1 (en) 1998-05-05 2001-02-13 Elan Corporation, Plc Subcutaneous drug delivery device with improved filling system
EP0990151A2 (en) 1997-06-16 2000-04-05 ELAN CORPORATION, Plc Methods of calibrating and testing a sensor for (in vivo) measurement of an analyte and devices for use in such methods
US6500150B1 (en) 1997-06-16 2002-12-31 Elan Pharma International Limited Pre-filled drug-delivery device and method of manufacture and assembly of same
US6200293B1 (en) * 1997-08-27 2001-03-13 Science Incorporated Fluid delivery device with temperature controlled energy source
US6086562A (en) * 1997-10-27 2000-07-11 Sarcos, Inc. Disposable automatic injection device
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US5957895A (en) * 1998-02-20 1999-09-28 Becton Dickinson And Company Low-profile automatic injection device with self-emptying reservoir
CA2325004A1 (en) * 1998-03-23 1999-09-30 Ehoud Carmel Drug delivery device
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
EP1082151A1 (en) * 1998-06-04 2001-03-14 ELAN CORPORATION, Plc Gas driven drug delivery device
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US7192713B1 (en) 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
US6458102B1 (en) * 1999-05-28 2002-10-01 Medtronic Minimed, Inc. External gas powered programmable infusion device
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6843781B2 (en) * 1999-10-14 2005-01-18 Becton, Dickinson And Company Intradermal needle
US20020095134A1 (en) * 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US6569143B2 (en) 1999-10-14 2003-05-27 Becton, Dickinson And Company Method of intradermally injecting substances
US6494865B1 (en) 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US20020156453A1 (en) * 1999-10-14 2002-10-24 Pettis Ronald J. Method and device for reducing therapeutic dosage
US20020193740A1 (en) 1999-10-14 2002-12-19 Alchas Paul G. Method of intradermally injecting substances
US6569123B2 (en) 1999-10-14 2003-05-27 Becton, Dickinson And Company Prefillable intradermal injector
US6776776B2 (en) * 1999-10-14 2004-08-17 Becton, Dickinson And Company Prefillable intradermal delivery device
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
US20010041869A1 (en) * 2000-03-23 2001-11-15 Causey James D. Control tabs for infusion devices and methods of using the same
US6485461B1 (en) 2000-04-04 2002-11-26 Insulet, Inc. Disposable infusion device
US20050008683A1 (en) * 2000-06-29 2005-01-13 Becton Dickinson And Company Method for delivering interferons to the intradermal compartment
US20040175360A1 (en) * 2000-06-29 2004-09-09 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US6620140B1 (en) * 2000-06-30 2003-09-16 Ethicon, Inc. Method and an apparatus for a port access system
US6589229B1 (en) 2000-07-31 2003-07-08 Becton, Dickinson And Company Wearable, self-contained drug infusion device
EP1309365B1 (en) 2000-08-18 2005-04-20 Becton Dickinson and Company Constant rate fluid delivery device with selectable flow rate and titratable bolus button
US6740059B2 (en) 2000-09-08 2004-05-25 Insulet Corporation Devices, systems and methods for patient infusion
US6669669B2 (en) 2001-10-12 2003-12-30 Insulet Corporation Laminated patient infusion device
CA2594576C (en) * 2000-11-09 2009-12-01 Insulet Corporation Transcutaneous delivery means
DE10057832C1 (en) 2000-11-21 2002-02-21 Hartmann Paul Ag Blood analysis device has syringe mounted in casing, annular mounting carrying needles mounted behind test strip and being swiveled so that needle can be pushed through strip and aperture in casing to take blood sample
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
WO2002064193A2 (en) * 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
CA2431420C (en) 2000-12-21 2011-10-11 Insulet Corporation Medical apparatus remote control and method
EP1381408A4 (en) 2001-02-22 2007-06-13 Insulet Corp Modular infusion device and method
EP2281573A3 (en) 2001-02-23 2011-12-07 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
WO2002067983A1 (en) * 2001-02-23 2002-09-06 Glaxosmithkline Biologicals S.A. Novel vaccine
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
WO2002083232A1 (en) * 2001-04-13 2002-10-24 Becton, Dickinson And Company Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption
JP4751009B2 (en) * 2001-04-13 2011-08-17 ベクトン・ディキンソン・アンド・カンパニー Prefillable intradermal delivery device with concealed needle and passive shield
DE10293048T1 (en) * 2001-04-27 2003-07-31 Glaxosmithkline Biolog Sa New vaccine
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
US20100221284A1 (en) 2001-05-30 2010-09-02 Saech-Sisches Serumwerk Dresden Novel vaccine composition
CA2448790C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Electric lancet actuator
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
ATE450209T1 (en) 2001-06-12 2009-12-15 Pelikan Technologies Inc APPARATUS AND METHOD FOR COLLECTING BLOOD SAMPLES
AU2002320094A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Integrated blood sampling analysis system with multi-use sampling module
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
AU2002348683A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
WO2002100461A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) * 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US20060018877A1 (en) * 2001-06-29 2006-01-26 Mikszta John A Intradermal delivery of vacccines and therapeutic agents
US20050010193A1 (en) * 2002-05-06 2005-01-13 Laurent Philippe E. Novel methods for administration of drugs and devices useful thereof
CA2451816A1 (en) 2001-06-29 2003-01-09 Becton, Dickinson And Company Intradermal delivery of vaccines and gene therapeutic agents via microcannula
US20030073609A1 (en) * 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US20030088238A1 (en) * 2001-09-26 2003-05-08 Poulsen Jens Ulrik Modular drug delivery system
US20060122577A1 (en) * 2001-09-26 2006-06-08 Poulsen Jens U Modular drug delivery system
US7344894B2 (en) 2001-10-16 2008-03-18 Agilent Technologies, Inc. Thermal regulation of fluidic samples within a diagnostic cartridge
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
US6939323B2 (en) * 2001-10-26 2005-09-06 Massachusetts Institute Of Technology Needleless injector
US20040120964A1 (en) * 2001-10-29 2004-06-24 Mikszta John A. Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
AU2002346399A1 (en) * 2001-11-14 2003-05-26 Medical Instill Technologies, Inc. Intradermal delivery device and method
US20030109827A1 (en) * 2001-12-07 2003-06-12 Elan Pharma International Limited Drug delivery system and method
JP4469610B2 (en) * 2002-02-04 2010-05-26 ベクトン・ディキンソン・アンド・カンパニー Skin access member
EP1476209B1 (en) * 2002-02-18 2008-07-30 Danfoss A/S Device for administering of medication in fluid form
EP1487519B1 (en) * 2002-02-26 2013-06-12 TecPharma Licensing AG Insertion device for an insertion set and method of using the same
US6692457B2 (en) 2002-03-01 2004-02-17 Insulet Corporation Flow condition sensor assembly for patient infusion device
US6830558B2 (en) 2002-03-01 2004-12-14 Insulet Corporation Flow condition sensor assembly for patient infusion device
US7214221B2 (en) 2002-03-26 2007-05-08 Becton, Dickinson And Company Multi-stage fluid delivery device and method
US7115108B2 (en) * 2002-04-02 2006-10-03 Becton, Dickinson And Company Method and device for intradermally delivering a substance
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7374544B2 (en) 2002-04-19 2008-05-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7481776B2 (en) 2002-04-19 2009-01-27 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7582099B2 (en) 2002-04-19 2009-09-01 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7524293B2 (en) 2002-04-19 2009-04-28 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7563232B2 (en) 2002-04-19 2009-07-21 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7410468B2 (en) 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7141058B2 (en) 2002-04-19 2006-11-28 Pelikan Technologies, Inc. Method and apparatus for a body fluid sampling device using illumination
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7052251B2 (en) * 2002-04-22 2006-05-30 Medtronic Minimed, Inc. Shape memory alloy wire driven positive displacement micropump with pulsatile output
US6656159B2 (en) 2002-04-23 2003-12-02 Insulet Corporation Dispenser for patient infusion device
US6960192B1 (en) 2002-04-23 2005-11-01 Insulet Corporation Transcutaneous fluid delivery system
US6656158B2 (en) 2002-04-23 2003-12-02 Insulet Corporation Dispenser for patient infusion device
US20060264886A9 (en) * 2002-05-06 2006-11-23 Pettis Ronald J Method for altering insulin pharmacokinetics
CA2484265C (en) * 2002-05-06 2012-08-07 Becton, Dickinson And Company Method and device for controlling drug pharmacokinetics
US6932796B2 (en) 2002-05-15 2005-08-23 Tearafuse, Inc. Liquid metering system
US20050005710A1 (en) * 2002-05-15 2005-01-13 Therafuse, Inc. Liquid metering system
US6979316B1 (en) 2002-05-23 2005-12-27 Seedlings Life Science Ventures Llc Apparatus and method for rapid auto-injection of medication
US6723072B2 (en) 2002-06-06 2004-04-20 Insulet Corporation Plunger assembly for patient infusion device
US20040147901A1 (en) * 2002-07-08 2004-07-29 Medical Instill Intradermal delivery device, and method of intradermal delivery
US7018360B2 (en) 2002-07-16 2006-03-28 Insulet Corporation Flow restriction system and method for patient infusion device
CA2493728C (en) * 2002-07-22 2013-10-29 Becton, Dickinson And Company Patch-like infusion device
CA2497086A1 (en) * 2002-08-30 2004-03-11 Becton, Dickinson And Company Method of controlling pharmacokinetics of immunomodulatory compounds
US20040049129A1 (en) * 2002-09-05 2004-03-11 Yan Qi Wafer assembly having a resilient extendable/retractable needle means for healthcare
AU2003270355A1 (en) * 2002-09-06 2004-03-29 Massachusetts Institute Of Technology Needless drug injection device
ES2287517T3 (en) * 2002-09-10 2007-12-16 Becton Dickinson And Company METHOD AND APPARATUS FOR THE EPIDERMIC ADMINISTRATION OF A SUBSTANCE.
WO2004024211A2 (en) 2002-09-12 2004-03-25 Children's Hospital Medical Center Method and device for painless injection of medication
US7128727B2 (en) 2002-09-30 2006-10-31 Flaherty J Christopher Components and methods for patient infusion device
US7144384B2 (en) 2002-09-30 2006-12-05 Insulet Corporation Dispenser components and methods for patient infusion device
US20060264926A1 (en) * 2002-11-08 2006-11-23 Kochamba Gary S Cutaneous stabilization by vacuum for delivery of micro-needle array
US6896666B2 (en) * 2002-11-08 2005-05-24 Kochamba Family Trust Cutaneous injection delivery under suction
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7252651B2 (en) * 2003-01-07 2007-08-07 Becton, Dickinson And Company Disposable injection device
EP1617888B1 (en) 2003-04-23 2019-06-12 Valeritas, Inc. Hydraulically actuated pump for long duration medicament administration
EP1475113A1 (en) * 2003-05-08 2004-11-10 Novo Nordisk A/S External needle inserter
ATE474611T1 (en) * 2003-05-08 2010-08-15 Novo Nordisk As AN INJECTION DEVICE THAT CAN BE APPLIED TO THE SKIN WITH A SEPARABLE ACTUATING PART FOR INSERTING THE NEEDLE
WO2004098683A1 (en) * 2003-05-08 2004-11-18 Novo Nordisk A/S Internal needle inserter
US6926694B2 (en) * 2003-05-09 2005-08-09 Medsolve Technologies, Llc Apparatus and method for delivery of therapeutic and/or diagnostic agents
ES2427641T3 (en) 2003-05-22 2013-10-31 Ibio, Inc. Recombinant vehicle molecule for expression, delivery and purification of target polypeptides
US8262614B2 (en) * 2003-05-30 2012-09-11 Pelikan Technologies, Inc. Method and apparatus for fluid injection
US20050137525A1 (en) * 2003-06-04 2005-06-23 Georgia Tech Research Corporation Drilling microneedle device
EP1633235B1 (en) 2003-06-06 2014-05-21 Sanofi-Aventis Deutschland GmbH Apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
WO2005016401A2 (en) * 2003-06-13 2005-02-24 Becton Dickinson And Company Improved intra-dermal delivery of biologically active agents
US7604592B2 (en) 2003-06-13 2009-10-20 Pelikan Technologies, Inc. Method and apparatus for a point of care device
DE10327254B4 (en) * 2003-06-17 2010-01-28 Disetronic Licensing Ag Modular infusion pump
EP1502613A1 (en) 2003-08-01 2005-02-02 Novo Nordisk A/S Needle device with retraction means
DK3395396T3 (en) 2003-08-12 2020-09-28 Becton Dickinson Co Plaster-like infusion device
CN100509069C (en) * 2003-08-12 2009-07-08 贝克顿·迪金森公司 Patch-like infusion device
JP2007503435A (en) * 2003-08-26 2007-02-22 ベクトン・ディキンソン・アンド・カンパニー Intradermal delivery of therapeutics
US20070185460A1 (en) 2003-08-28 2007-08-09 Lionel Vedrine Intradermal injection device
WO2005034949A1 (en) * 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
US7361155B2 (en) * 2003-09-16 2008-04-22 Therafuse, Inc. Compensating liquid delivery system and method
IL157981A (en) 2003-09-17 2014-01-30 Elcam Medical Agricultural Cooperative Ass Ltd Auto-injector
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc METHOD AND APPARATUS FOR AN IMPROVED SAMPLING INTERFERENCE DEVICE
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc METHOD AND DEVICE FOR A VARIABLE USER INTERFACE
ATE446111T1 (en) 2003-10-21 2009-11-15 Novo Nordisk As INTERNAL FLUID CONNECTOR FOR PRODUCING A FLUID CONNECTION
WO2005037184A2 (en) * 2003-10-21 2005-04-28 Novo Nordisk A/S Reservoir device with integrated mounting means
KR20060099520A (en) 2003-10-21 2006-09-19 노보 노르디스크 에이/에스 Medical Skin Mounting Device
DE602004022075D1 (en) * 2003-10-21 2009-08-27 Novo Nordisk As RESERVOIR DEVICE WITH INTEGRATED FASTENER
WO2005037185A2 (en) * 2003-10-21 2005-04-28 Novo Nordisk A/S Reservoir device with inclined needle
EP1527792A1 (en) * 2003-10-27 2005-05-04 Novo Nordisk A/S Medical injection device mountable to the skin
PL1682203T3 (en) 2003-10-23 2010-06-30 Novo Nordisk As Medical injection device mountable to the skin
DE602004025025D1 (en) * 2003-10-27 2010-02-25 Novo Nordisk As ON THE SKIN FIXABLE MEDICAL INJECTION DEVICE
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2005065414A2 (en) 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
US7150726B2 (en) * 2004-01-23 2006-12-19 Norfolk Medical Device for subcutaneous infusion of fluids
WO2005079441A2 (en) 2004-02-17 2005-09-01 Children's Hospital Medical Center Injection device for administering a vaccine
WO2005091922A2 (en) * 2004-03-03 2005-10-06 Becton, Dickinson And Company Methods and devices for improving delivery of a substance to skin
US7108679B2 (en) * 2004-03-11 2006-09-19 Becton, Dickinson And Company Intradermal syringe and needle assembly
IL160891A0 (en) 2004-03-16 2004-08-31 Auto-mix needle
MXPA06010923A (en) 2004-03-26 2006-12-15 Unomedical As Infusion set.
CN100586495C (en) 2004-03-30 2010-02-03 诺和诺德公司 Actuator system comprising lever mechanism
JP4432650B2 (en) * 2004-04-26 2010-03-17 株式会社日立製作所 FUEL CELL POWER SUPPLY, ITS OPERATION METHOD AND PORTABLE ELECTRONIC DEVICE USING FUEL CELL POWER SUPPLY
EP1744784A2 (en) * 2004-05-11 2007-01-24 Becton, Dickinson and Company Formulations of anti-pain agents and methods of using the same
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1755522A1 (en) * 2004-06-07 2007-02-28 Novo Nordisk A/S Reservoir with liquidly applied seal
WO2006014425A1 (en) 2004-07-02 2006-02-09 Biovalve Technologies, Inc. Methods and devices for delivering glp-1 and uses thereof
US8062250B2 (en) 2004-08-10 2011-11-22 Unomedical A/S Cannula device
CN101027095B (en) * 2004-09-22 2010-09-29 诺和诺德公司 Medical Devices with Cannula Inserters
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
WO2006077263A1 (en) 2005-01-24 2006-07-27 Novo Nordisk A/S Transcutaneous device assembly
US7833189B2 (en) 2005-02-11 2010-11-16 Massachusetts Institute Of Technology Controlled needle-free transport
US20070060904A1 (en) * 2005-03-14 2007-03-15 Becton, Dickinson And Company Filling system and method for syringes with short needles
US7985199B2 (en) 2005-03-17 2011-07-26 Unomedical A/S Gateway system
CA2602456A1 (en) 2005-03-23 2006-09-28 Glaxosmithkline Biologicals S.A. Composition
EP1866296B1 (en) 2005-04-04 2016-11-02 University of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
US8298172B2 (en) * 2005-04-13 2012-10-30 Novo Nordisk A/S Medical skin mountable device and system
US7569050B2 (en) 2005-05-06 2009-08-04 Medtronic Minimed, Inc. Infusion device and method with drive device in infusion device and method with drive device in separable durable housing portion
US20080097291A1 (en) * 2006-08-23 2008-04-24 Hanson Ian B Infusion pumps and methods and delivery devices and methods with same
KR101446025B1 (en) * 2005-08-03 2014-10-01 아이바이오, 인크. Compositions and methods for production of immunoglobulins
ES2354107T3 (en) 2005-09-12 2011-03-10 Unomedical A/S INSERTION DEVICE FOR AN INFUSION TEAM WITH A FIRST AND SECOND SPRING UNITS.
CN101262897A (en) * 2005-09-13 2008-09-10 诺沃-诺迪斯克有限公司 Memory device with examination aid for drug condition detection
JP2009511223A (en) * 2005-10-17 2009-03-19 ノボ・ノルデイスク・エー/エス Vented drug reservoir unit
EP2210632B1 (en) * 2005-11-02 2012-01-18 Injectica AG Implantable infusion device with advanceable and retractable needle
TWI457133B (en) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa Novel composition
US9267937B2 (en) 2005-12-15 2016-02-23 Massachusetts Institute Of Technology System for screening particles
AU2006329072B2 (en) 2005-12-23 2012-07-26 Unomedical A/S Device for administration
CN104162200B (en) * 2006-02-09 2018-03-27 德卡产品有限公司 peripheral system
CA2642054C (en) * 2006-02-13 2017-11-21 Fraunhofer Usa, Inc. Influenza antigens, vaccine compositions, and related methods
US8277816B2 (en) * 2006-02-13 2012-10-02 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
EP1984388B1 (en) * 2006-02-13 2016-07-06 iBio, Inc. Hpv antigens, vaccine compositions, and related methods
US20070191780A1 (en) * 2006-02-16 2007-08-16 Pankaj Modi Drug delivery device
KR20080104342A (en) 2006-02-28 2008-12-02 우노메디컬 에이/에스 Injection part with needle guard and insert for injection part
EP1998684A4 (en) * 2006-03-10 2014-09-17 Massachusetts Inst Technology CONJUGATES TO SELF-ASSEMBLY TRIGGERED AND NANOSYSTEMS
JP2009530880A (en) 2006-03-13 2009-08-27 ノボ・ノルデイスク・エー/エス Secure pairing of electronic devices using complex communication means
ES2493921T3 (en) 2006-03-14 2014-09-12 University Of Southern California MEMS device for the administration of therapeutic agents
US7666912B2 (en) 2006-03-23 2010-02-23 Massachusetts Eye And Ear Infirmary Compositions and methods for reducing body fat
JP2007252551A (en) * 2006-03-23 2007-10-04 Shimadzu Corp Disc-shaped needleless syringe
ES2656675T3 (en) * 2006-03-30 2018-02-28 Valeritas, Inc. Multi-cartridge fluid supply device
JP2009534309A (en) 2006-03-31 2009-09-24 マサチューセッツ インスティテュート オブ テクノロジー System for targeted delivery of therapeutic agents
WO2007120638A2 (en) * 2006-04-12 2007-10-25 President And Fellows Of Harvard College Methods and compositions for modulating glycosylation
EP2019691B1 (en) 2006-05-15 2020-08-12 Massachusetts Institute of Technology Polymers for functional particles
EP2492684B1 (en) 2006-06-02 2016-12-28 President and Fellows of Harvard College Protein surface remodeling
EP2032188A1 (en) 2006-06-06 2009-03-11 Novo Nordisk A/S Assembly comprising skin-mountable device and packaging therefore
KR20090026760A (en) 2006-06-07 2009-03-13 우노메디컬 에이/에스 Injector
AU2007256563B2 (en) 2006-06-09 2012-09-27 Unomedical A/S Mounting pad
US9381477B2 (en) 2006-06-23 2016-07-05 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
PT2043682E (en) 2006-07-17 2014-07-11 Glaxosmithkline Biolog Sa Influenza vaccine
PL2048955T3 (en) 2006-07-21 2013-11-29 California Inst Of Techn Targeted gene delivery for dendritic cell vaccination
DK2043706T3 (en) * 2006-07-24 2016-04-04 Hoffmann La Roche SYSTEMS, DEVICES AND PROCEDURES FOR FLUID / MEDICINE ADMINISTRATION
CN101522234B (en) * 2006-07-24 2012-11-14 梅丁格有限公司 Systems, devices and methods for fluid/drug delivery
US9115358B2 (en) * 2006-08-11 2015-08-25 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
CA2660038A1 (en) * 2006-08-14 2008-06-19 Massachusetts Institute Of Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
US20090269342A1 (en) * 2006-08-14 2009-10-29 Massachusetts Institute Of Technology Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
WO2008042814A2 (en) 2006-09-29 2008-04-10 California Institute Of Technology Mart-1 t cell receptors
JO3598B1 (en) 2006-10-10 2020-07-05 Infinity Discovery Inc Boronic acids and esters as inhibitors of fatty acid amide hydrolase
US8202267B2 (en) 2006-10-10 2012-06-19 Medsolve Technologies, Inc. Method and apparatus for infusing liquid to a body
EP1917990A1 (en) 2006-10-31 2008-05-07 Unomedical A/S Infusion set
FR2909001B1 (en) * 2006-11-24 2009-12-18 Bernard Perriere MINIATURIZED AND AUTOMATIC INJECTION AND SAMPLING DEVICE FOR MEDICAL USE.
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
US20090093551A1 (en) * 2006-12-08 2009-04-09 Bhatia Sangeeta N Remotely triggered release from heatable surfaces
ES2804801T3 (en) 2006-12-26 2021-02-09 Lantheus Medical Imaging Inc Ligands for imaging of cardiac innervation
CA2677045C (en) 2007-01-31 2016-10-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
EP2134830A2 (en) 2007-02-09 2009-12-23 Massachusetts Institute of Technology Oscillating cell culture bioreactor
NZ579994A (en) 2007-03-15 2011-09-30 Univ Florida Desferrithiocin polyether analogues useful in the treatment of pathological conditions responsive to chelation or sequestration of trivalent metal
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
CA2682174C (en) * 2007-03-28 2021-04-06 President And Fellows Of Harvard College Stitched polypeptides
US20090074828A1 (en) 2007-04-04 2009-03-19 Massachusetts Institute Of Technology Poly(amino acid) targeting moieties
WO2008124634A1 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Polymer-encapsulated reverse micelles
PL3375470T3 (en) 2007-04-10 2024-05-13 F. Hoffmann-La Roche Ag Apparatus and method for pumping fluid
KR100876650B1 (en) * 2007-04-13 2009-01-09 (주) 비에이치케이 Vascular access devices
EP2152301A4 (en) * 2007-04-28 2010-07-28 Fraunhofer Usa Inc TRYPANOSOME ANTIGENS, VACCINE COMPOSITIONS AND RELATED METHODS
BRPI0811459A8 (en) * 2007-06-14 2015-09-22 Berna Biotech Ag VIROSOMIC PREPARATION, USE OF A VIROSOMAL PREPARATION, KIT, AND METHODS TO VACCINATE A HUMAN AGAINST INFLUENZA INFECTIONS, AND TO VACCINATE INDIVIDUALS MAMMALIANS AGAINST INFLUENZA INFECTIONS
US8524444B2 (en) 2007-06-15 2013-09-03 President And Fellows Of Harvard College Methods and compositions for detections and modulating O-glycosylation
DK2155311T3 (en) 2007-06-20 2013-02-04 Unomedical As METHOD AND APPARATUS FOR PREPARING A CATHETIC
NZ582194A (en) 2007-07-03 2011-08-26 Unomedical As Inserter for injecting medication having bistable equilibrium states
US8486003B2 (en) 2007-07-10 2013-07-16 Unomedical A/S Inserter having two springs
WO2009009759A2 (en) 2007-07-11 2009-01-15 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
EP2022518A1 (en) * 2007-08-07 2009-02-11 Sensile Pat AG Modular drug delivery device for administering discrete doses of a medicament
CA2696764A1 (en) * 2007-08-20 2009-02-26 Fraunhofer Usa, Inc. Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
US8409145B2 (en) 2007-09-17 2013-04-02 Tecpharma Licensing Ag Insertion devices for infusion devices
US7771391B2 (en) * 2007-09-28 2010-08-10 Calibra Medical, Inc. Disposable infusion device with snap action actuation
US9345836B2 (en) 2007-10-02 2016-05-24 Medimop Medical Projects Ltd. Disengagement resistant telescoping assembly and unidirectional method of assembly for such
US9656019B2 (en) 2007-10-02 2017-05-23 Medimop Medical Projects Ltd. Apparatuses for securing components of a drug delivery system during transport and methods of using same
US7967795B1 (en) 2010-01-19 2011-06-28 Lamodel Ltd. Cartridge interface assembly with driving plunger
EP2195052B1 (en) 2007-10-02 2019-09-04 Medimop Medical Projects Ltd. External drug pump
US10420880B2 (en) 2007-10-02 2019-09-24 West Pharma. Services IL, Ltd. Key for securing components of a drug delivery system during assembly and/or transport and methods of using same
US8604004B2 (en) * 2007-10-04 2013-12-10 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
CA2917512C (en) 2007-10-12 2025-08-05 President And Fellows Of Harvard College Vaccine nanotechnology
US8858787B2 (en) 2007-10-22 2014-10-14 Baxter International Inc. Dialysis system having non-invasive fluid velocity sensing
CA2701772A1 (en) 2007-10-31 2009-05-07 Novo Nordisk A/S Non-porous material as sterilization barrier
US9308124B2 (en) 2007-12-20 2016-04-12 University Of Southern California Apparatus and methods for delivering therapeutic agents
CN101951927A (en) * 2008-01-03 2011-01-19 麻省理工学院 Decoy influenza therapies
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8708961B2 (en) 2008-01-28 2014-04-29 Medsolve Technologies, Inc. Apparatus for infusing liquid to a body
JP2011511688A (en) 2008-02-13 2011-04-14 ウノメディカル アクティーゼルスカブ Seal between cannula part and flow path
AU2009216703A1 (en) 2008-02-20 2009-08-27 Unomedical A/S Insertion device with horizontally moving part
JP5385260B2 (en) * 2008-03-28 2014-01-08 テルモ株式会社 Syringe
WO2009126691A1 (en) 2008-04-09 2009-10-15 Infinity Pharmaceuticals, Inc Inhibitors of fatty acid amide hydrolase
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
WO2009134808A2 (en) * 2008-04-28 2009-11-05 President And Fellows Of Harvard College Supercharged proteins for cell penetration
US9333297B2 (en) 2008-05-08 2016-05-10 Minipumps, Llc Drug-delivery pump with intelligent control
US9199035B2 (en) 2008-05-08 2015-12-01 Minipumps, Llc. Drug-delivery pumps with dynamic, adaptive control
EP2898911A1 (en) 2008-05-08 2015-07-29 MiniPumps, LLC Implantable pumps and cannulas therefor
US9162024B2 (en) 2008-05-08 2015-10-20 Minipumps, Llc Drug-delivery pumps and methods of manufacture
CA2726836C (en) 2008-06-26 2019-06-18 Anterios, Inc. Use of nanoemulsions in the manufacture of a medicament for treating skin disorders
ES2442024T3 (en) 2008-07-15 2014-02-07 Academia Sinica Glucan matrices on glass slides coated with PTFE type aluminum and related methods
FR2933872B1 (en) * 2008-07-18 2012-09-28 Bernard Perriere MINIATURIZED INJECTION DEVICE FOR MEDICAL USE WITH REMOVABLE CARTRIDGE
US20110144306A1 (en) * 2008-07-23 2011-06-16 President And Fellows Of Harvard College Ligation of stapled polypeptides
US20100075926A1 (en) * 2008-07-23 2010-03-25 Li-Huei Tsai Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
US8986250B2 (en) * 2008-08-01 2015-03-24 Wisconsin Alumni Research Foundation Drug delivery platform utilizing hydrogel pumping mechanism
US8795259B2 (en) * 2008-08-01 2014-08-05 Wisconsin Alumni Research Foundation Drug delivery platform incorporating hydrogel pumping mechanism with guided fluid flow
EP3701981A1 (en) * 2008-08-18 2020-09-02 Calibra Medical LLC Drug infusion system with reusable and disposable components
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US12097357B2 (en) 2008-09-15 2024-09-24 West Pharma. Services IL, Ltd. Stabilized pen injector
US9393369B2 (en) 2008-09-15 2016-07-19 Medimop Medical Projects Ltd. Stabilized pen injector
WO2010037046A1 (en) 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Humanized neuraminidase antibody and methods of use thereof
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US20100145305A1 (en) * 2008-11-10 2010-06-10 Ruth Alon Low volume accurate injector
US20100130958A1 (en) * 2008-11-26 2010-05-27 David Kang Device and Methods for Subcutaneous Delivery of High Viscosity Fluids
WO2010077806A1 (en) 2008-12-15 2010-07-08 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways
RU2011130565A (en) 2008-12-22 2013-01-27 Уномедикал А/С MEDICAL DEVICE CONTAINING ADHESIVE GASKET
CA2749877A1 (en) * 2008-12-22 2010-07-01 Greenlight Biosciences, Inc. Compositions and methods for the production of a compound
US8152779B2 (en) * 2008-12-30 2012-04-10 Medimop Medical Projects Ltd. Needle assembly for drug pump
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9250106B2 (en) 2009-02-27 2016-02-02 Tandem Diabetes Care, Inc. Methods and devices for determination of flow reservoir volume
WO2010118155A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
EP2417115A4 (en) 2009-04-07 2012-10-31 Infinity Pharmaceuticals Inc Inhibitors of fatty acid amide hydrolase
EP2424877A4 (en) 2009-04-28 2013-01-02 Harvard College SUPERCHARGED PROTEINS FOR CELL PENETRATION
US9149465B2 (en) * 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8927551B2 (en) * 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) * 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
WO2010141074A2 (en) 2009-06-01 2010-12-09 President And Fellows Of Harvard College O-glcnac transferase inhibitors and uses thereof
CA2768299C (en) 2009-07-13 2018-03-20 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
SG177744A1 (en) 2009-07-24 2012-02-28 Immune Design Corp Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
MX2012000774A (en) 2009-07-30 2013-12-02 Unomedical As Inserter device with horizontal moving part.
AU2010278894B2 (en) 2009-07-30 2014-01-30 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
KR20120047896A (en) * 2009-08-07 2012-05-14 우노메디컬 에이/에스 Delivery device with sensor and one or more cannulas
WO2011028716A1 (en) * 2009-09-01 2011-03-10 Massachusetts Institute Of Technology Nonlinear system identification technique for testing the efficacy of skin care products
US8758271B2 (en) * 2009-09-01 2014-06-24 Massachusetts Institute Of Technology Nonlinear system identification techniques and devices for discovering dynamic and static tissue properties
US8157769B2 (en) 2009-09-15 2012-04-17 Medimop Medical Projects Ltd. Cartridge insertion assembly for drug delivery system
US10071196B2 (en) 2012-05-15 2018-09-11 West Pharma. Services IL, Ltd. Method for selectively powering a battery-operated drug-delivery device and device therefor
JP5629775B2 (en) 2009-09-15 2014-11-26 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Self-injector
US10071198B2 (en) 2012-11-02 2018-09-11 West Pharma. Servicees IL, Ltd. Adhesive structure for medical device
AU2010298338A1 (en) 2009-09-22 2012-04-12 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
US8784819B2 (en) 2009-09-29 2014-07-22 Ibio Inc. Influenza hemagglutinin antibodies, compositions and related methods
CN104474606B (en) * 2009-10-13 2017-04-26 瓦莱里塔斯公司 Fluid delivery device
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US20110143310A1 (en) 2009-12-15 2011-06-16 Hunter Ian W Lorentz-Force Actuated Cleaning Device
DK2512560T3 (en) 2009-12-16 2018-07-16 Becton Dickinson Co Even injector device
WO2011075099A1 (en) 2009-12-16 2011-06-23 Becton, Dickinson And Company Self-injection device
ES2714698T3 (en) 2009-12-16 2019-05-29 Becton Dickinson Co Auto injection device
DK2512552T3 (en) 2009-12-16 2015-06-08 Becton Dickinson Co Self Injection Device
DK2512579T3 (en) 2009-12-16 2017-03-13 Becton Dickinson Co Self Injection Device
IN2012DN05230A (en) 2009-12-16 2015-10-23 Becton Dickinson Co
CA2784807C (en) 2009-12-29 2021-12-14 Dana-Farber Cancer Institute, Inc. Type ii raf kinase inhibitors
US8348898B2 (en) 2010-01-19 2013-01-08 Medimop Medical Projects Ltd. Automatic needle for drug pump
JP6210685B2 (en) 2010-01-27 2017-10-11 マサチューセッツ インスティテュート オブ テクノロジー Engineered polypeptide agents for targeted broad spectrum influenza neutralization
MX336742B (en) * 2010-02-03 2016-01-29 Infinity Pharmaceuticals Inc Fatty acid amide hydrolase inhibitors.
EA025443B1 (en) 2010-03-08 2016-12-30 Слоан-Кеттеринг Институт Фор Кэнсер APPLICATION AS A Cdc7 KINASE INHIBITOR GRANATICINE B
EA201290929A1 (en) * 2010-03-19 2013-04-30 Хелозим, Инк. DEVICE FOR DELIVERY OF MEDICINE SUBSTANCE UNDER GAS PRESSURE
EP2550285B1 (en) 2010-03-22 2017-07-19 President and Fellows of Harvard College Trioxacarcins and uses thereof
US9415159B2 (en) 2010-03-30 2016-08-16 Unomedical A/S Medical device
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8285328B2 (en) 2010-04-20 2012-10-09 Minipumps, Llc Remote-controlled drug pump devices
US8450350B2 (en) 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
WO2011140190A1 (en) 2010-05-05 2011-11-10 Infinity Pharmaceuticals Tetrazolones as inhibitors of fatty acid synthase
KR20130071433A (en) 2010-05-07 2013-06-28 그린라이트 바이오사이언시스, 아이엔씨. Methods for control of flux in metabolic pathways through enzyme relocation
WO2011141907A1 (en) 2010-05-10 2011-11-17 Medimop Medical Projects Ltd. Low volume accurate injector
KR102008635B1 (en) 2010-05-11 2019-08-07 랜티우스 메디컬 이메징, 인크. Compositions, methods and systems for the synthesis and use of imaging agents
KR20180037303A (en) 2010-06-07 2018-04-11 암젠 인크 Drug delivery device
JP5857043B2 (en) 2010-06-18 2016-02-10 大鵬薬品工業株式会社 PRPK-TPRKB modulator and use thereof
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
WO2012021875A1 (en) 2010-08-13 2012-02-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles with triazole linkers
DK3219796T3 (en) 2010-08-31 2020-12-21 Greenlight Biosciences Inc PROCEDURES FOR MONITORING FLOW IN METABOLIC REACTIONS BY PROTEASE MANIPULATION
JP5843862B2 (en) 2010-09-02 2016-01-13 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Self-injection device with needle cover with anti-start device
WO2012040406A2 (en) 2010-09-21 2012-03-29 Massachusetts Institute Of Technology Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
US8585677B2 (en) 2010-09-21 2013-11-19 Brigham Young University Laminar injection apparatus and method
WO2012040459A2 (en) 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
US8915879B2 (en) 2010-09-24 2014-12-23 Perqflo, Llc Infusion pumps
EP2433663A1 (en) 2010-09-27 2012-03-28 Unomedical A/S Insertion system
ES3005233T3 (en) 2010-10-01 2025-03-14 Modernatx Inc Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
EP2436412A1 (en) 2010-10-04 2012-04-04 Unomedical A/S A sprinkler cannula
SG189236A1 (en) 2010-10-04 2013-05-31 Massachusetts Inst Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
EP2438938A1 (en) * 2010-10-11 2012-04-11 PharmaSens AG Syringe type pump
US9211378B2 (en) 2010-10-22 2015-12-15 Cequr Sa Methods and systems for dosing a medicament
CN103298474B (en) 2010-11-10 2016-06-29 无限药品股份有限公司 Heterocyclic compound and application thereof
US8905972B2 (en) 2010-11-20 2014-12-09 Perqflo, Llc Infusion pumps
US8795234B2 (en) * 2010-11-30 2014-08-05 Becton, Dickinson And Company Integrated spring-activated ballistic insertion for drug infusion device
EP2460553A1 (en) 2010-12-02 2012-06-06 Debiotech S.A. Device for inserting needles
AR084824A1 (en) 2011-01-10 2013-06-26 Intellikine Inc PROCESSES TO PREPARE ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONAS
EP2982373B1 (en) 2011-01-19 2018-06-13 Topokine Therapeutics, Inc. Methods and compostions for reducing body fat
US20120191074A1 (en) * 2011-01-21 2012-07-26 Palyon Medical (Bvi) Limited Reduced sized programmable pump
EP2667859A2 (en) 2011-01-24 2013-12-04 Anterios, Inc. Nanoparticle compositions, formulations thereof, and uses therefor
EP2667945A1 (en) 2011-01-24 2013-12-04 Anterios, Inc. Oil compositions
SG193970A1 (en) 2011-01-24 2013-11-29 Anterios Inc Nanoparticle compositions
KR20140010126A (en) 2011-03-03 2014-01-23 터서스 파마수티칼 엘엘씨 Compositions and methods comprising c16:1n7-palmitoleate
USD702834S1 (en) 2011-03-22 2014-04-15 Medimop Medical Projects Ltd. Cartridge for use in injection device
WO2012135615A2 (en) 2011-03-30 2012-10-04 Brown University Enopeptins, uses thereof, and methods of synthesis thereto
US20130281932A1 (en) * 2011-03-30 2013-10-24 Ziv Harish Palm-based injector actuation and safety surfaces
US20120253314A1 (en) * 2011-03-30 2012-10-04 Ziv Harish Palm-controlled injectors
DE12722942T1 (en) 2011-03-31 2021-09-30 Modernatx, Inc. RELEASE AND FORMULATION OF MANIPULATED NUCLEIC ACIDS
EP2723384B1 (en) 2011-06-22 2018-08-29 The General Hospital Corporation Treatment of proteinopathies
CA2842190A1 (en) 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
WO2013012915A1 (en) 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
EP3483150A1 (en) 2011-07-22 2019-05-15 Massachusetts Institute Of Technology Activators of class 1 histone deacetylases (hdacs) and uses thereof
WO2013032841A1 (en) 2011-08-29 2013-03-07 Sid Technologies Llc Subcutaneous and intradermal patch infusers
CN103998442B (en) 2011-08-29 2016-09-14 无限药品股份有限公司 Heterocyclic compound and application thereof
DK2753605T3 (en) 2011-09-09 2019-06-17 Lantheus Medical Imaging Inc COMPOSITIONS, METHODS AND SYSTEMS FOR THE SYNTHESIS AND THE APPLICATION OF IMAGE CRAFTS
JP2014526250A (en) 2011-09-09 2014-10-06 グリーンライト バイオサイエンシーズ インコーポレーテッド Cell-free preparation of carbapenem
EP3384938A1 (en) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9630979B2 (en) 2011-09-29 2017-04-25 Infinity Pharmaceuticals, Inc. Inhibitors of monoacylglycerol lipase and methods of their use
RU2648950C2 (en) 2011-10-03 2018-04-02 Модерна Терапьютикс, Инк. Modified nucleosides, nucleotides and nucleic acids and their application
CN103957962B (en) 2011-10-05 2017-07-07 犹诺医药有限公司 Inserts for simultaneous insertion of multiple percutaneous sections
CN108929375A (en) 2011-10-18 2018-12-04 爱勒让治疗公司 Peptidomimetic macrocyclic compound
EP2583715A1 (en) 2011-10-19 2013-04-24 Unomedical A/S Infusion tube system and method for manufacture
US9440051B2 (en) 2011-10-27 2016-09-13 Unomedical A/S Inserter for a multiplicity of subcutaneous parts
WO2013074986A1 (en) 2011-11-17 2013-05-23 Dana-Farber Cancer Institute, Inc. Inhibitors of c-jun-n-terminal kinase (jnk)
GB201120000D0 (en) 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
GB201119999D0 (en) 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
KR102111176B1 (en) 2011-12-16 2020-05-15 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 Uses of 4'-desferrithiocin analogs
AU2012352180A1 (en) 2011-12-16 2014-07-31 Moderna Therapeutics, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
US10335545B2 (en) 2012-01-31 2019-07-02 West Pharma. Services IL, Ltd. Time dependent drug delivery apparatus
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CN112500466B (en) 2012-02-15 2022-05-03 艾瑞朗医疗公司 Peptidomimetic macrocycles
US10668213B2 (en) 2012-03-26 2020-06-02 West Pharma. Services IL, Ltd. Motion activated mechanisms for a drug delivery device
US9463280B2 (en) 2012-03-26 2016-10-11 Medimop Medical Projects Ltd. Motion activated septum puncturing drug delivery device
US9072827B2 (en) 2012-03-26 2015-07-07 Medimop Medical Projects Ltd. Fail safe point protector for needle safety flap
WO2013149186A1 (en) 2012-03-30 2013-10-03 Insulet Corporation Fluid delivery device with transcutaneous access tool, insertion mechansim and blood glucose monitoring for use therewith
NZ700340A (en) 2012-03-30 2017-02-24 Immune Design Corp Lentiviral vector particles having improved transduction efficiency for cells expressing dc- sign
US10106833B2 (en) 2012-04-06 2018-10-23 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
EP2834254A2 (en) 2012-04-06 2015-02-11 President and Fellows of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
US9902985B2 (en) 2012-04-06 2018-02-27 President And Fellows Of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
SG11201406769RA (en) 2012-05-10 2014-11-27 Massachusetts Inst Technology Agents for influenza neutralization
EP2662110A1 (en) 2012-05-10 2013-11-13 Debiotech S.A. Device and method for inserting needles
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
SG11201500573RA (en) 2012-08-06 2015-02-27 Glaxosmithkline Biolog Sa Method for eliciting in infants an immune response against rsv and b. pertussis
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
WO2014046950A1 (en) 2012-09-24 2014-03-27 Enable Injections, Llc Medication vial and injector assemblies and methods of use
SMT202100337T1 (en) 2012-09-26 2021-07-12 Harvard College Proline-locked stapled peptides and uses thereof
WO2014055564A1 (en) 2012-10-01 2014-04-10 President And Fellows Of Harvard College Stabilized polypeptide insulin receptor modulators
CA2887701C (en) 2012-10-12 2020-12-15 The Broad Institute, Inc. Gsk3 inhibitors and methods of use thereof
BR112015008224A2 (en) * 2012-10-16 2017-07-04 Swissinnov Product Sarl fluid release device for releasing small amounts of fluid to a patient, system for releasing small amounts of fluid for a patient, detachable adjustable bifunctional connector on the fluid release device and method for installing the fluid release device in a patient
EP2909194A1 (en) 2012-10-18 2015-08-26 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
USRE48175E1 (en) 2012-10-19 2020-08-25 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged small molecules as inducers of protein degradation
WO2014063054A1 (en) 2012-10-19 2014-04-24 Dana-Farber Cancer Institute, Inc. Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
HRP20181367T4 (en) 2012-11-01 2021-11-26 Infinity Pharmaceuticals, Inc. TREATMENT OF CANCER USING PI3 KINASE ISOFORM MODULATORS
CN104812384B (en) 2012-11-01 2020-09-18 爱勒让治疗公司 Disubstituted amino acids and methods of making and using the same
US9567301B2 (en) 2012-11-02 2017-02-14 Dana-Farber Cancer Institute, Inc. Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors
SG11201600237YA (en) 2012-11-21 2016-02-26 Topokine Therapeutics Inc Methods and compositions for locally increasing body fat
HRP20220607T1 (en) 2012-11-26 2022-06-24 Modernatx, Inc. Terminally modified rna
US9775915B2 (en) 2012-11-26 2017-10-03 President And Fellows Of Harvard College Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof
JP2016505001A (en) 2012-12-21 2016-02-18 エピザイム,インコーポレイティド PRMT5 inhibitors and uses thereof
HUE040323T2 (en) 2012-12-21 2019-02-28 Epizyme Inc PRMT5 inhibitors and their applications
EP2935243B1 (en) 2012-12-21 2018-03-14 Epizyme, Inc. Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
US9908887B2 (en) 2012-12-21 2018-03-06 Epizyme, Inc. PRMT5 inhibitors and uses thereof
US9421323B2 (en) 2013-01-03 2016-08-23 Medimop Medical Projects Ltd. Door and doorstop for portable one use drug delivery apparatus
EP2946014A2 (en) 2013-01-17 2015-11-25 Moderna Therapeutics, Inc. Signal-sensor polynucleotides for the alteration of cellular phenotypes
WO2014124228A1 (en) 2013-02-07 2014-08-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
RU2708447C2 (en) 2013-02-07 2019-12-06 Массачусетс Инститьют Оф Текнолоджи Adaptation of influenza virus h5 to human
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
JP6568515B2 (en) 2013-03-13 2019-08-28 プレジデント アンド フェローズ オブ ハーバード カレッジ Stapled and stitched polypeptides and uses thereof
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US9180243B2 (en) 2013-03-15 2015-11-10 Tandem Diabetes Care, Inc. Detection of infusion pump conditions
US11246842B2 (en) 2014-12-18 2022-02-15 Windgap Medical, Inc. Method and compositions for dissolving or solubilizing therapeutic agents
US20160024051A1 (en) 2013-03-15 2016-01-28 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
AU2014248090B2 (en) 2013-04-03 2018-08-02 N-Fold Llc Novel nanoparticle compositions
AU2014248014B2 (en) 2013-04-04 2018-11-08 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
WO2014169073A1 (en) 2013-04-09 2014-10-16 Massachusetts Institute Of Technology Drug delivery polymer and uses thereof
WO2014179464A1 (en) 2013-04-30 2014-11-06 Massachusetts Institute Of Technology Human adaptation of h3 influenza
US9011164B2 (en) 2013-04-30 2015-04-21 Medimop Medical Projects Ltd. Clip contact for easy installation of printed circuit board PCB
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
US9889256B2 (en) 2013-05-03 2018-02-13 Medimop Medical Projects Ltd. Sensing a status of an infuser based on sensing motor control and power input
NO2753788T3 (en) 2013-05-10 2018-06-16
EP2803376A1 (en) * 2013-05-16 2014-11-19 Georg Fischer Novel active emergency supply valve
EP3003309B1 (en) 2013-05-30 2020-09-09 Infinity Pharmaceuticals, Inc. Treatment of cancers using pi3 kinase isoform modulators
US10526375B2 (en) 2013-06-05 2020-01-07 Massachusetts Institute Of Technology Human Adaptation of H7 HA
CA2914815A1 (en) 2013-06-11 2014-12-18 Kala Pharmaceuticals, Inc. Urea derivatives and uses thereof
CN105492460A (en) 2013-06-14 2016-04-13 哈佛大学的校长及成员们 Stabilized polypeptide insulin receptor modulators
CN105339024B (en) * 2013-06-18 2020-05-05 因内博注射剂公司 Apparatus and method for vial transfer and injection
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
EP3024327B1 (en) 2013-07-25 2019-09-04 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
US9688977B2 (en) 2013-08-05 2017-06-27 Greenlight Biosciences, Inc. Engineered phosphoglucose isomerase proteins with a protease cleavage site
EP3030260A1 (en) 2013-08-05 2016-06-15 GlaxoSmithKline Biologicals S.A. Combination immunogenic compositions
EP3041484B1 (en) 2013-09-06 2021-03-03 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
MX389256B (en) 2013-10-04 2025-03-20 Infinity Pharmaceuticals Inc HETEROCYCLIC COMPOUNDS AND THEIR USES.
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2015057894A1 (en) 2013-10-15 2015-04-23 Massachusetts Institute Of Technology Methods for treating polycystic kidney disease and polycystic liver disease
WO2015057958A2 (en) 2013-10-16 2015-04-23 Massachusetts Institute Of Technology Enterobactin conjugates and uses thereof
ES2676734T3 (en) 2013-10-18 2018-07-24 Syros Pharmaceuticals, Inc. Heteroatomic compounds useful for the treatment of proliferative diseases
US10047070B2 (en) 2013-10-18 2018-08-14 Dana-Farber Cancer Institute, Inc. Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
US20160244452A1 (en) 2013-10-21 2016-08-25 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9458169B2 (en) 2013-11-01 2016-10-04 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
KR20160101162A (en) 2013-12-24 2016-08-24 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Cortistatin analogues and syntheses and uses thereof
JP2017507118A (en) 2014-01-16 2017-03-16 アカデミア シニカAcademia Sinica Compositions and methods for the treatment and detection of cancer
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
JP6625071B2 (en) 2014-03-07 2019-12-25 ザ アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ Non-drug CRMP2 peptides targeting sodium channels for chronic pain
CN113616656B (en) 2014-03-19 2023-02-17 无限药品股份有限公司 Heterocyclic compounds for the treatment of PI 3K-gamma mediated disorders
TWI687428B (en) 2014-03-27 2020-03-11 中央研究院 Reactive labelling compounds and uses thereof
JP6836400B2 (en) 2014-03-28 2021-03-03 ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャリゼーション Breast and ovarian cancer vaccines
WO2015164604A1 (en) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged janus kinase inhibitors and uses thereof
WO2015164614A1 (en) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Janus kinase inhibitors and uses thereof
WO2015168079A1 (en) 2014-04-29 2015-11-05 Infinity Pharmaceuticals, Inc. Pyrimidine or pyridine derivatives useful as pi3k inhibitors
US10039816B2 (en) 2014-04-30 2018-08-07 Massachusetts Institute Of Technology Siderophore-based immunization against gram-negative bacteria
EP3145523A4 (en) 2014-05-21 2018-02-21 President and Fellows of Harvard College Ras inhibitory peptides and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CA2950423A1 (en) 2014-05-27 2015-12-03 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
EP3149036A4 (en) 2014-05-27 2017-12-27 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
KR102512592B1 (en) 2014-05-27 2023-03-21 아카데미아 시니카 Anti-her2 glycoantibodies and uses thereof
AU2015267044A1 (en) 2014-05-28 2016-12-15 Academia Sinica Anti-TNF-alpha glycoantibodies and uses thereof
JP6664338B2 (en) 2014-06-13 2020-03-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Immunogenic combination
SMT201900142T1 (en) 2014-06-19 2019-05-10 Ariad Pharma Inc Heteroaryl compounds for kinase inhibition
WO2015200425A1 (en) 2014-06-27 2015-12-30 Topokine Therapeutics, Inc. Topical dosage regimen
WO2016004202A1 (en) 2014-07-02 2016-01-07 Massachusetts Institute Of Technology Polyamine-fatty acid derived lipidoids and uses thereof
CN106715458A (en) 2014-07-18 2017-05-24 华盛顿大学 Cancer vaccine compositions and methods of use thereof
US10736966B2 (en) 2014-08-12 2020-08-11 Massachusetts Institute Of Technology Brush-poly (glycoamidoamine)-lipids and uses thereof
WO2016040369A2 (en) 2014-09-08 2016-03-17 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US10905739B2 (en) 2014-09-24 2021-02-02 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
EP3197478A4 (en) 2014-09-24 2018-05-30 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US10159786B2 (en) 2014-09-30 2018-12-25 Perqflo, Llc Hybrid ambulatory infusion pumps
US12178992B2 (en) 2014-09-30 2024-12-31 Medtronic Minimed, Inc. Different disposable assemblies for the same reusable assembly
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
CN111888368B (en) 2014-10-21 2024-02-02 武田药品工业株式会社 Crystalline forms of 5-chloro-N4- [2- (dimethylphosphoryl) phenyl ] -N2- { 2-methoxy-4- [4- (4-methylpiperazin-1-yl) piperidin-1-yl ] phenyl } pyrimidine-2, 4-diamine
US20180015101A1 (en) 2014-10-28 2018-01-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for antigen-specific tolerance
EP3461904A1 (en) 2014-11-10 2019-04-03 ModernaTX, Inc. Alternative nucleic acid molecules containing reduced uracil content and uses thereof
WO2016086026A1 (en) 2014-11-26 2016-06-02 Kala Pharmaceuticals, Inc. Crystalline forms of a therapeutic compound and uses thereof
WO2016094710A1 (en) 2014-12-10 2016-06-16 Kala Pharmaceuticals, Inc. 1 -amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
EP3236959B1 (en) 2014-12-23 2025-09-24 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
CA2972266C (en) 2014-12-23 2023-05-09 Sloan-Kettering Institute For Cancer Research Polymorph of granaticin b
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
KR102691114B1 (en) 2015-01-24 2024-08-01 아카데미아 시니카 Novel glycan conjugates and methods of using them
EP3650060B1 (en) 2015-02-18 2021-09-29 Medtronic Minimed, Inc. Ambulatory infusion pumps and reservoir assemblies for use with same
AU2016219961B2 (en) 2015-02-18 2020-07-02 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
US9730625B2 (en) * 2015-03-02 2017-08-15 Verily Life Sciences Llc Automated blood sampling device
US10765361B2 (en) * 2015-03-02 2020-09-08 Verily Life Sciences Llc Automated sequential injection and blood draw
US10251813B2 (en) 2015-03-04 2019-04-09 West Pharma. Services IL, Ltd. Flexibly mounted cartridge alignment collar for drug delivery device
US9795534B2 (en) 2015-03-04 2017-10-24 Medimop Medical Projects Ltd. Compliant coupling assembly for cartridge coupling of a drug delivery device
SG11201707750YA (en) 2015-03-20 2017-10-30 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
WO2016160617A2 (en) 2015-03-27 2016-10-06 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
AU2016243623B2 (en) 2015-03-30 2022-04-14 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
US9744297B2 (en) 2015-04-10 2017-08-29 Medimop Medical Projects Ltd. Needle cannula position as an input to operational control of an injection device
US10293120B2 (en) 2015-04-10 2019-05-21 West Pharma. Services IL, Ltd. Redundant injection device status indication
WO2016176343A1 (en) 2015-04-27 2016-11-03 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
US10149943B2 (en) 2015-05-29 2018-12-11 West Pharma. Services IL, Ltd. Linear rotation stabilizer for a telescoping syringe stopper driverdriving assembly
EP4252798A3 (en) 2015-06-04 2023-10-25 Medimop Medical Projects Ltd. Cartridge insertion for drug delivery device
AU2016276963C1 (en) 2015-06-12 2021-08-05 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
RS64331B1 (en) 2015-06-19 2023-08-31 Massachusetts Inst Technology Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
WO2017004548A1 (en) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
JP7028766B2 (en) 2015-09-09 2022-03-02 ダナ-ファーバー キャンサー インスティテュート, インコーポレイテッド Inhibitor of cyclin-dependent kinase
CN108368161A (en) 2015-09-10 2018-08-03 艾瑞朗医疗公司 Peptidomimetic macrocyclic compound as MCL-1 conditioning agents
CN114230571B (en) 2015-09-14 2025-07-08 无限药品股份有限公司 Solid forms of isoquinolinones, methods of making, compositions comprising, and methods of using the same
EP4101930A1 (en) 2015-09-17 2022-12-14 ModernaTX, Inc. Polynucleotides containing a stabilizing tail region
ES2910425T3 (en) 2015-09-17 2022-05-12 Modernatx Inc Compounds and compositions for the intracellular delivery of therapeutic agents
US9987432B2 (en) 2015-09-22 2018-06-05 West Pharma. Services IL, Ltd. Rotation resistant friction adapter for plunger driver of drug delivery device
US10576207B2 (en) 2015-10-09 2020-03-03 West Pharma. Services IL, Ltd. Angled syringe patch injector
WO2017059389A1 (en) 2015-10-01 2017-04-06 Kythera Biopharmaceuticals, Inc. Compositions comprising a statin for use in methods of adipolysis
CN113648488B (en) 2015-10-09 2024-03-29 西医药服务以色列分公司 Curved fluid path attachment to prefilled fluid reservoir
EP3738973A1 (en) 2015-11-09 2020-11-18 Immune Design Corp. Compositions comprising lentiviral vectors expressing il-12 and methods of use thereof
US11135283B2 (en) 2015-11-09 2021-10-05 Immune Design Corp. Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
US10716896B2 (en) 2015-11-24 2020-07-21 Insulet Corporation Wearable automated medication delivery system
WO2017091584A1 (en) 2015-11-25 2017-06-01 Insulet Corporation Wearable medication delivery device
SMT202200252T1 (en) 2015-12-22 2022-07-21 Modernatx Inc Compounds and compositions for intracellular delivery of agents
US10275573B2 (en) 2016-01-13 2019-04-30 Bigfoot Biomedical, Inc. User interface for diabetes management system
CN112933333B (en) 2016-01-14 2023-03-28 比格福特生物医药公司 Adjusting insulin delivery rate
HK1256995A1 (en) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. Occlusion resolution in medication delivery devices, systems, and methods
WO2017127215A1 (en) 2016-01-21 2017-07-27 Medimop Medical Projects Ltd. Needle insertion and retraction mechanism
CN109219456B (en) 2016-01-21 2020-05-15 西医药服务以色列有限公司 Force containment in autoinjectors
US11311674B2 (en) 2016-01-21 2022-04-26 West Pharma. Services IL, Ltd. Medicament delivery device comprising a visual indicator
WO2017136268A1 (en) 2016-02-04 2017-08-10 Insulet Corporation Anti-inflammatory cannula
US10940264B2 (en) 2016-02-12 2021-03-09 Medtronic Minimed, Inc. Ambulatory infusion pumps and assemblies for use with same
EA201891717A1 (en) 2016-02-23 2019-02-28 Иммьюн Дизайн Корп. PREPARATIONS OF MULTI-GENOMIC RETROVIRAL VECTORS AND METHODS AND SYSTEMS FOR THEIR RECEPTION AND APPLICATION
TW201808978A (en) 2016-03-08 2018-03-16 中央研究院 Methods for modular synthesis of N-glycans and arrays thereof
US9827369B2 (en) * 2016-03-16 2017-11-28 Baxter International Inc. Percutaneous administration device and method for injecting medicinal substances
WO2017161076A1 (en) 2016-03-16 2017-09-21 Medimop Medical Projects Ltd. Staged telescopic screw assembly having different visual indicators
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
EP3440215A1 (en) 2016-04-06 2019-02-13 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
CN109310831B (en) 2016-06-02 2021-11-23 西医药服务以色列有限公司 Three position needle retraction
CN109563138B (en) 2016-06-03 2022-09-23 圣诺菲·帕斯图尔公司 Modification of engineered influenza hemagglutinin polypeptides
US10105449B2 (en) 2016-06-07 2018-10-23 Massachusetts Institute Of Technology Drug delivery polymers and uses thereof
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
JP2019525901A (en) 2016-06-14 2019-09-12 モデルナティエックス インコーポレイテッドModernaTX,Inc. Stabilized preparation of lipid nanoparticles
EP3490643B1 (en) 2016-08-01 2021-10-27 West Pharma. Services Il, Ltd. Anti-rotation cartridge pin
WO2018026385A1 (en) 2016-08-01 2018-02-08 Medimop Medical Projects Ltd. Partial door closure prevention spring
CA3031797A1 (en) 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
TWI789357B (en) 2016-08-05 2023-01-11 南韓商Sk生物科技股份有限公司 Multivalent pneumococcal polysaccharide-protein conjugate composition
US10538592B2 (en) 2016-08-22 2020-01-21 Cho Pharma, Inc. Antibodies, binding fragments, and methods of use
US10765807B2 (en) 2016-09-23 2020-09-08 Insulet Corporation Fluid delivery device with sensor
WO2018060024A1 (en) * 2016-09-27 2018-04-05 Sanofi-Aventis Deutschland Gmbh A medicament delivery device
CN110035783B (en) * 2016-09-27 2022-04-12 赛诺菲-安万特德国有限公司 Medicament delivery device
WO2018060026A1 (en) 2016-09-27 2018-04-05 Sanofi-Aventis Deutschland Gmbh A medicament delivery device
WO2018060023A1 (en) * 2016-09-27 2018-04-05 Sanofi-Aventis Deutschland Gmbh A medicament delivery device
US11583504B2 (en) 2016-11-08 2023-02-21 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
AU2017360346B2 (en) 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
WO2018106738A1 (en) 2016-12-05 2018-06-14 Massachusetts Institute Of Technology Brush-arm star polymers, conjugates and particles, and uses thereof
AU2017376111B2 (en) 2016-12-12 2023-02-02 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
CA3046816A1 (en) 2016-12-15 2018-06-21 Pka Softtouch Corp. Intradermal drug delivery device having a locked post-dispensing configuration
WO2018132723A1 (en) 2017-01-13 2018-07-19 Mazlish Bryan Insulin delivery methods, systems and devices
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP3568859B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10881793B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US20210338928A1 (en) * 2017-01-23 2021-11-04 Enable Injections, Inc. Medical fluid injection device with fill indicator
US20180207369A1 (en) * 2017-01-23 2018-07-26 Enable Injections, Inc. Medical fluid injection device with fill indicator
WO2018148180A2 (en) 2017-02-07 2018-08-16 Immune Design Corp. Materials and methods for identifying and treating cancer patients
WO2018156548A1 (en) 2017-02-22 2018-08-30 Insulet Corporation Needle insertion mechanisms for drug containers
CA3055653A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Lipid nanoparticle formulation
SI3596041T1 (en) 2017-03-15 2023-02-28 Modernatx, Inc. Compound and compositions for intracellular delivery of therapeutic agents
WO2018175324A1 (en) 2017-03-20 2018-09-27 The Broad Institute, Inc. Compounds and methods for regulating insulin secretion
EP3606528B1 (en) 2017-04-05 2023-10-18 The Broad Institute, Inc. Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof
WO2018222521A1 (en) 2017-05-30 2018-12-06 West Pharma. Services IL, Ltd. Modular drive train for wearable injector
EP3638678B1 (en) 2017-06-14 2025-12-03 ModernaTX, Inc. Compounds and compositions for intracellular delivery of agents
US11260171B2 (en) 2017-07-04 2022-03-01 Medtronic Minimed, Inc. Ambulatory infusion pumps and assemblies for use with same
WO2019013789A1 (en) 2017-07-12 2019-01-17 Curza Global, Llc Antimicrobial compounds
WO2019013790A1 (en) 2017-07-12 2019-01-17 Curza Global, Llc Antimicrobial compounds and uses thereof
WO2019046809A1 (en) 2017-08-31 2019-03-07 Modernatx, Inc. Methods of making lipid nanoparticles
US10898656B2 (en) 2017-09-26 2021-01-26 Insulet Corporation Needle mechanism module for drug delivery device
AR113764A1 (en) 2017-10-11 2020-06-10 Greenlight Biosciences Inc METHODS AND COMPOSITIONS FOR THE PRODUCTION OF NUCLEOSIDE TRIPHOSPHATE AND RIBONUCLEIC ACID
US11147931B2 (en) 2017-11-17 2021-10-19 Insulet Corporation Drug delivery device with air and backflow elimination
US11786477B2 (en) 2017-12-01 2023-10-17 North Carolina State University Fibrin particles and methods of making the same
JP7402799B2 (en) 2017-12-22 2023-12-21 ウェスト ファーマ サービシーズ イスラエル リミテッド Syringes available with different cartridge sizes
EP3749358A4 (en) 2018-02-05 2022-04-20 Sanofi Pasteur, Inc. MULTIVALENT POLYSACCHARIDE-PNEUMOCOCCAL PROTEIN CONJUGATE COMPOSITION
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11583633B2 (en) 2018-04-03 2023-02-21 Amgen Inc. Systems and methods for delayed drug delivery
CN112236826B (en) 2018-05-04 2024-08-13 英赛罗公司 Safety constraints for drug delivery systems based on control algorithms
CN112367991A (en) 2018-06-25 2021-02-12 达纳-法伯癌症研究所股份有限公司 TAIRE family kinase inhibitors and uses thereof
EP3849540A1 (en) 2018-09-13 2021-07-21 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
MX2021002995A (en) 2018-09-13 2021-07-15 Eirion Therapeutics Inc Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor.
US12263248B2 (en) 2018-09-19 2025-04-01 Modernatx, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
WO2020061457A1 (en) 2018-09-20 2020-03-26 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
AU2019347755B2 (en) 2018-09-28 2023-02-02 Insulet Corporation Activity mode for artificial pancreas system
US11565039B2 (en) 2018-10-11 2023-01-31 Insulet Corporation Event detection for drug delivery system
CN113423381A (en) 2018-12-03 2021-09-21 艾里奥治疗公司 Improved delivery of large agents
EP3902542A4 (en) 2018-12-28 2022-09-07 Dana-Farber Cancer Institute, Inc. CYCLIN DEPENDENT KINASE 7 INHIBITORS AND USES THEREOF
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
JP2022518230A (en) 2019-01-16 2022-03-14 カーザ グローバル, エルエルシー Antibacterial compounds and methods
AU2020209170B2 (en) 2019-01-16 2025-09-04 Curza Global, Llc Antimicrobial compounds and methods
CA3128215A1 (en) 2019-01-31 2020-08-06 Modernatx, Inc. Methods of preparing lipid nanoparticles
WO2020168466A1 (en) 2019-02-19 2020-08-27 Stemirna Therapeutics Co., Ltd. Modified nucleoside and synthetic methods thereof
AU2020274082A1 (en) 2019-05-14 2022-01-20 Eirion Therapeutics, Inc. Delaying peak effect and/or extending duration of response
US20220280639A1 (en) 2019-07-31 2022-09-08 Modernatx, Inc. Compositions and methods for delivery of rna interference agents to immune cells
KR20220042378A (en) 2019-07-31 2022-04-05 사노피 파스퇴르 인코포레이티드 Polyvalent pneumococcal polysaccharide-protein conjugate composition and method of use thereof
WO2021034858A1 (en) * 2019-08-22 2021-02-25 Verily Life Sciences Llc Capillary blood collection using varying number of lancets
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
JP7682173B2 (en) 2019-11-13 2025-05-23 カーザ グローバル, エルエルシー Antimicrobial compounds and methods
US11957875B2 (en) 2019-12-06 2024-04-16 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
EP4088286A1 (en) 2020-01-06 2022-11-16 Insulet Corporation Prediction of meal and/or exercise events based on persistent residuals
JP2023513043A (en) 2020-01-31 2023-03-30 モデルナティエックス インコーポレイテッド Method for preparing lipid nanoparticles
WO2021158580A1 (en) 2020-02-03 2021-08-12 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
WO2021173965A1 (en) 2020-02-28 2021-09-02 Massachusetts Institute Of Technology Identification of variable influenza residues and uses thereof
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
WO2021231729A1 (en) 2020-05-13 2021-11-18 Sanofi Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
WO2022020197A1 (en) 2020-07-22 2022-01-27 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
WO2022072332A1 (en) 2020-09-30 2022-04-07 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
EP4221588A1 (en) 2020-09-30 2023-08-09 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
US20230174576A1 (en) 2020-10-30 2023-06-08 Xeno-Interface Inc. Beta-strand bridge peptide
CN117083065A (en) 2020-10-30 2023-11-17 庆应义塾 Novel treatment and prevention of sarcopenia-related diseases and the like
TW202237068A (en) 2020-12-09 2022-10-01 美商建南德克公司 High-throughput methods for preparing lipid nanoparticles and uses thereof
WO2022133218A1 (en) 2020-12-18 2022-06-23 Insulet Corporation Adhesive pad with a metallic coil for securing an on-body medical device
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
CN112972821A (en) * 2021-02-04 2021-06-18 四川大学华西医院 Postoperative is with safe continuous automatic electron pressure analgesia infusion device
US12433847B2 (en) 2021-03-09 2025-10-07 Massachusetts Institute Of Technology Branched poly(-amino esters) for the delivery of nucleic acids
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US12431229B2 (en) 2021-03-10 2025-09-30 Insulet Corporation Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
TW202313065A (en) 2021-05-28 2023-04-01 美商季卡尼醫療公司 Compounds for treating genetic diseases
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
EP4101482A1 (en) 2021-06-07 2022-12-14 Insulet Corporation Exercise safety prediction based on physiological conditions
WO2023018817A1 (en) 2021-08-11 2023-02-16 Sanofi Pasteur Inc. Truncated influenza neuraminidase and methods of using the same
WO2023038778A1 (en) * 2021-08-19 2023-03-16 Innovative Health Strategies Llc A smart self-activating wearable device for automatically injecting medicines
EP4409581A1 (en) 2021-09-27 2024-08-07 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
AU2022361432A1 (en) 2021-10-08 2024-05-23 Sanofi Pasteur Inc. Multivalent influenza vaccines
CN118302190A (en) 2021-11-05 2024-07-05 赛诺菲 Hybrid multivalent influenza vaccine comprising hemagglutinin and neuraminidase and methods of use thereof
IL312545A (en) 2021-11-05 2024-07-01 Sanofi Pasteur Inc Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
US12171779B2 (en) 2021-12-08 2024-12-24 University Of South Florida Regulated drug delivery via controlled degradable chondroitin sulfate particles
TW202333654A (en) 2021-12-16 2023-09-01 美商現代公司 Processes for preparing lipid nanoparticles
US20250084041A1 (en) 2021-12-30 2025-03-13 Curza Global, Llc Antimicrobial compounds and methods
EP4470563A1 (en) 2022-01-25 2024-12-04 Motoshi Hayano New therapy and prevention for suppressing aging-related disorders including sarcopenia
JP2025503207A (en) 2022-01-27 2025-01-30 サノフィ・パスツール Modified Vero cells and methods of using same for virus production
CN114632218B (en) * 2022-03-14 2024-03-08 重庆倍加医疗器械有限公司 Pneumatic driving injection device
EP4494148A1 (en) 2022-03-14 2025-01-22 Sanofi Pasteur Inc. Machine-learning techniques in protein design for vaccine generation
WO2023193002A1 (en) 2022-04-01 2023-10-05 Modernatx, Inc. Cross mixers for lipid nanoparticle production, and methods of operating the same
WO2023235380A1 (en) 2022-06-01 2023-12-07 Zikani Therapeutics, Inc. Macrolides for treating genetic diseases
WO2023250513A1 (en) 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
WO2024026475A1 (en) 2022-07-29 2024-02-01 Modernatx, Inc. Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
US20250375391A1 (en) 2022-07-29 2025-12-11 Modernatx, Inc. Lipid nanoparticle compositions comprising surface lipid derivatives and relates uses
US20250375389A1 (en) 2022-07-29 2025-12-11 Modernatx, Inc. Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
KR20250053926A (en) 2022-09-01 2025-04-22 지카니 테라퓨틱스, 인크. Treatment of familial adenomatous polyposis with 13-one macrolides
WO2024091918A2 (en) 2022-10-25 2024-05-02 Modernatx, Inc. Methods of lipid nanoparticle production in cross-mixers
WO2024121380A1 (en) 2022-12-08 2024-06-13 Pierre Fabre Medicament Vaccinal composition and adjuvant
KR20250129777A (en) 2023-01-06 2025-08-29 인슐렛 코포레이션 Automatically or manually initiated food bolus delivery with subsequent automatic safety constraint relief
WO2024246358A1 (en) 2023-06-01 2024-12-05 Sanofi Thermostable compositions comprising mrna lipid nanoparticles
WO2024259373A1 (en) 2023-06-14 2024-12-19 Modernatx, Inc. Compounds and compositions for delivery of therapeutic agents
WO2025051975A1 (en) 2023-09-06 2025-03-13 Sanofi Modified influenza b hemagglutinin polypeptides and nucleic acids and uses thereof
WO2025064449A1 (en) 2023-09-18 2025-03-27 Eirion Therapeutics, Inc. Topical compositions and uses of pai-1 inhibitors
WO2025160127A1 (en) 2024-01-23 2025-07-31 Modernatx, Inc. Ionizable lipids and compositions thereof for delivery of therapeutic agents
WO2025160381A1 (en) 2024-01-26 2025-07-31 Modernatx, Inc. Methods of preparing lipid nanoparticles
WO2025166202A1 (en) 2024-01-31 2025-08-07 Modernatx, Inc. Lipid nanoparticle compositions comprising sialic acid derivatives and the uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB207710A (en) * 1923-08-29 1923-12-06 George Henry Watts Improvements in horse and like shoes
SU787035A1 (en) * 1978-01-11 1980-12-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Device for injection of medical preparations
CA1169323A (en) * 1980-06-03 1984-06-19 Anthony M. Albisser Insulin infusion device
US4316463A (en) * 1981-01-26 1982-02-23 Vac-O-Cast, Inc. Corrosive protected hypodermic module
US4340048A (en) * 1981-03-28 1982-07-20 Alza Corporation Self-driven hypodermic injector
US4525164A (en) * 1981-04-24 1985-06-25 Biotek, Inc. Wearable medication infusion system with arcuated reservoir
SE436687B (en) * 1981-12-14 1985-01-21 Anders Blomberg INJECTION DEVICE
AU8704582A (en) * 1982-03-15 1983-09-22 Ralph Franco Aid for inserting needle
DE3227051A1 (en) * 1982-07-20 1984-02-02 B. Braun Melsungen Ag, 3508 Melsungen HOSE PUMP, ESPECIALLY FOR MEDICAL APPLICATIONS
US4552561A (en) * 1982-12-23 1985-11-12 Alza Corporation Body mounted pump housing and pump assembly employing the same
DE3417757C2 (en) * 1984-05-12 1994-11-10 Lucas Dieter Dr Hypodermic syringe
DE3577039D1 (en) * 1984-06-21 1990-05-17 David R Fischell FINGER-ACTUATED INFUSION SYSTEM FOR THE MEDICAL SUPPLY.
JPS61176336A (en) * 1985-01-31 1986-08-08 オリンパス光学工業株式会社 Treatment jig for endoscope
US4626244A (en) * 1985-02-01 1986-12-02 Consolidated Controls Corporation Implantable medication infusion device
EP0375673A3 (en) * 1985-03-20 1990-08-01 Knight, Robert Leonard Harry An infusion apparatus
US4596556A (en) * 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4734092A (en) * 1987-02-18 1988-03-29 Ivac Corporation Ambulatory drug delivery device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5848990A (en) * 1993-10-22 1998-12-15 Hoffmann-La Roche Inc. Device for introducing active substance into a patient

Also Published As

Publication number Publication date
PH26445A (en) 1992-07-15
AU8266387A (en) 1988-06-23
ATE68358T1 (en) 1991-11-15
EP0272530A2 (en) 1988-06-29
AU620536B2 (en) 1992-02-20
DK665887D0 (en) 1987-12-17
EP0272530A3 (en) 1988-08-31
IL84811A (en) 1993-02-21
JPS63164963A (en) 1988-07-08
EP0272530B1 (en) 1991-10-16
JP2648314B2 (en) 1997-08-27
DK665887A (en) 1988-06-19
IL84811A0 (en) 1988-06-30
KR880007095A (en) 1988-08-26
IE60868B1 (en) 1994-08-24
ZA879351B (en) 1988-06-20
DE3773867D1 (en) 1991-11-21
CA1283827C (en) 1991-05-07
DK170660B1 (en) 1995-11-27
KR960000845B1 (en) 1996-01-13
US4886499A (en) 1989-12-12
HK27494A (en) 1994-03-31
IE873430L (en) 1988-06-18

Similar Documents

Publication Publication Date Title
US4886499A (en) Portable injection appliance
US6723072B2 (en) Plunger assembly for patient infusion device
US6485461B1 (en) Disposable infusion device
EP1432464B1 (en) Modular drug delivery system
EP1513580B1 (en) Plunger assembly for patient infusion device
CA3013081C (en) Flexible and conformal patch pump
US20040078028A1 (en) Plunger assembly for patient infusion device
EP0850076B1 (en) Medicament delivery device
EP1700615B1 (en) Device for intradermal medicament delivery
US20070299397A1 (en) Infusion device with pressurizable liquid medicament chamber
US20030088238A1 (en) Modular drug delivery system
US20060122577A1 (en) Modular drug delivery system
WO1997041917A1 (en) Fluid delivery apparatus and method
CA2498722A1 (en) Method and device for painless injection of medication
CA1154345A (en) Controlled infusion apparatus and method
CA2492836C (en) Administration device comprising an osmotic drive
CN119215261A (en) Fluid conveying device and fluid conveying system
EP4572818A1 (en) Cartridge assembly with integrated infusion catheter and cgm sensor subassembly